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Individuals with Parkinson’s disease (PD) often show cognitive impairments in addition 
to motor symptoms, with the majority of PD patients converting to dementia as the disease 
progresses. The changes in the microstructural integrity of key nodes in resting state networks 
(RSNs) could be a good indicator of the cognitive effects of PD on brain regions as it progresses 
to dementia. To assess the association between cognitive effects and microstructural change, the 
microstructural integrity of the regions of interest (ROIs) in 4 resting state networks (RSN), 
specifically the default mode network (DMN), based on DTI were obtained in three separate 
groups of patients with PD. One group of patients (PD-N) were cognitively normal, while the 
second group of patients (PD-MCI) reflect the transitional phase of mild cognitive impairment 
prior to dementia, and the third group of patients (PD-D) possessed a clear diagnosis of 
dementia. A comparison group of healthy controls (HC) were included, matched across the three 
patient groups. The PD-D group showed worse microstructural integrity for the majority of the 
ROIs across the 4 networks. The loss of structural integrity in the PD-MCI group was more 
selective, with some ROIs showing similar changes to PD-D, and others showing similar 
changes to the PD-N group. The PD-N group fail to show any changes in the structural integrity 
of any ROIs, relative to HC. For future study, a combined structural / functional study should be 
performed to examine if there are similar changes across both measures.  
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1. Introduction 
1.1 Parkinson’s Disease 
 
Parkinson’s disease (PD) is the second most common aging-related neurodegenerative 
disorder, following Alzheimer’s Disease (AD), with a male to female ratio of 2:1 in most studies 
(Meireles & Massano, 2012; Wirdefeldt, Adami, Cole, Trichopoulos, & Mandel, 2012). PD is an 
idiopathic motor disorder that is associated with the degeneration of nigrostriatal dopamine 
neurons, related to the presence of Lewy bodies in brain-stem nigral and extranigral neurons 
(Wirdefeldt et al., 2012). Various risk factors are implicated in the development of PD, including 
exposure to pesticides and other toxics, positive family history of PD and aging, which is the 
most significant risk factor documented so far (Hindle, 2010; Schapira & Jenner, 2011; Thal, Del 
Tredici, & Braak, 2004; Wirdefeldt et al., 2012). PD is diagnosed by identifying the classical 
motor symptoms of bradykinesia, rigidity, tremor, and postural instability (Guttman, Kish, & 
Furukawa, 2003 ; Jankovic, 2008). Other manifestations of PD include psychiatric symptoms 
such as anxiety and depression and dysautonomic symptoms such as orthostatic hypotension, 
constipation, sexual dysfunction and weight loss (Jankovic, 2008; Meireles & Massano, 2012). 
In addition, cognitive impairment is now recognised as a major feature of PD (Svenningsson,  
Westman, Ballard, & Aarsland, 2012). 
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1.2 Cognitive Impairments in PD 
 
A growing body of neuropsychological evidence shows that patients with PD have 
diverse cognitive problems affecting visuospatial abilities, memory, and executive functioning, 
even at relatively early stages of the disease (Bosboom, Stoffers, & Wolters, 2004; Dagher & 
Nagano-Saito, 2007; Goldman, Baty, Buckles, Sahrmann, & Morris, 1998; Ibarrexte-Bilbao, 
Junque , Marti, & Tolosa, 2011; Williams-Gray, Foltynie, Brayne, Robbins, & Barker, 2007). 
 Many patients with PD endure cognitive decline, often sufficient to be categorized as 
mild cognitive impairment (PD-MCI), a diagnosis that can be defined as cognitive deterioration 
that is considered abnormal for the patient’s age, but with retention of daily functioning 
(Aarsland et al., 2010; Barone et al., 2011; Goldman & Litvan, 2011 ; Jellinger, 2013). PD-MCI 
can include not only memory impairment, but impairments in language, attention, executive 
function and visuospatial function as well (Caviness et al., 2007).  
As the specific criteria of PD-MCI vary widely across different groups based on different 
populations and methodology (Dalrymple-Alford et al., 2011), there has been a recent proposal 
of consensus criteria for PD-MCI (Litvan et al., 2012; see Method for definition). The prevalence 
of PD-MCI is estimated to be approximately 20 – 30% of non-demented PD patients (Aarsland 
et al., 2010; Goldman & Litvan, 2011; Meireles & Massano, 2012). Patients with PD-MCI are at 
an increased risk of developing dementia, compared to those without MCI (Broeders et al., 2013; 
Janvin , Larsen, Aarsland, & Hugdahl, 2006; Weintraub et al., 2012). 
A highly important facet of PD is that cognitive decline in the majority results in a 
cumulative prevalence of dementia as high as 75% - 85% of patients, such that PD patients have 
a four- to six-fold chance of developing dementia, compared to healthy elderly people (Aarsland 
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et al., 2007; Emre et al., 2007; Hobson & Meara, 2007). Dementia has a substantial impact on 
both caregivers and is associated with increased mortality and morbidity rate as well as a higher 
risk for nursing home placement (Callahan et al., 2012; Gaugler, Mittelman, Hepburn, & 
Newcomer, 2010; Hughes, Ross, Mindham, & Spokes, 2004; Posada et al., 2011).  
Therefore, it is important to elucidate the underlying neurobiological changes that may be 
implicated in the progression to dementia in patients with PD. One such neurobiological 
mechanism is the impairment of key resting-state cognitive networks. 
1.3 Resting-State Networks 
 
Functional magnetic resonance imaging (fMRI) studies when participants are not 
engaged in an external task (resting state, RS) have demonstrated that spontaneous fluctuations 
in activity within separate brain regions (‘nodes’) exhibit a strong temporal correlation, which 
suggests that these regions form different functional cognitive networks (Damoiseaux et al., 
2006; Deco, Jirsa, & McIntosh, 2011; Fox & Raichle, 2007; Mantini, Perrucci, Gratta, Romani, 
& Corbetta, 2007). Several such networks have been identified, and these networks are spatially 
consistent across subjects and across different testing sessions (Jeong, Choi, & Kim, 2012; 
Shehzad et al., 2009). These networks, each termed a ‘resting-state network’ (RSN), have been 
suggested to represent the fundamental functional organization of the brain that represents 
various cognitive processes (van den Heuvel & Pol, 2010; Rosazza & Minati, 2011). 
During the last decade, one RSN and its associated set of brain regions has become the 
object of intensive focus and research in neuroscience. This particular RSN is often referred to as 
the default mode network (DMN), which has been identified in an emerging body of evidence 
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that demonstrates a consistent pattern of activity across a network of specific brain nodal regions 
that include the posterior cingulate cortex (PCC), medial prefrontal cortex - both ventral and 
dorsal regions (vMPFC/dMPFC), inferior parietal lobule (IPL), and middle temporal gyrus 
(MTG), all of which were reported across many studies in a very high degree of reliability; the 
hippocampus is often reported as well but was observed as relatively less robust than the specific 
regions (Andrews-Hanna, Reidler, Sepulcre, Poulin, & Buckner, 2010; Buckner, Andrews-
Hanna, & Schacter, 2008; Greicius, Krasnow, Reiss, & Menon, 2003; Heuvel, Mandl, Kahn, & 
Pol, 2009; Heuvel & Pol, 2010; Long et al., 2008; Raichle et al., 2001). Although deactivated 
during task performance, the DMN is active in the resting brain with a high degree of functional 
connectivity (FC) between these component regions (Greicius, Krasnow, Reiss, & Menon, 2003; 
Greicius, Supekar, Menon, & Dougherty, 2009; Long et al., 2008; Raichle, 2011; Raichle & 
Snyder, 2007).  
This resting state activity in the brain has been termed the default-mode brain activity to 
denote a high-energy expenditure state in which an individual is awake and alert, but not actively 
involved in an attention demanding or goal directed externally driven task (Fransson, 2006; 
Raichle et al., 2001; Raichle, 2011). In other words, the DMN is engaged when individuals are 
left to think to themselves undisturbed (e.g., resting quietly but awake with eyes closed or open 
or passively viewing a particular visual image) (Raichle et al., 2001; Raichle & Snyder, 2007). 
The term ‘deactivation’ was often used because analyses and image visualization of brain scans 
were referenced to a target, experimental task. Within this context, regions relatively more active 
in a target condition (e.g., reading or classifying pictures) compared to the control task (e.g., 
passive fixation of an image, rest with eyes open or closed) were labelled ‘activation’. Thus, 
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reduced activity when target condition was compared to the control condition was labelled 
‘deactivation’ (Buckner et al., 2008). 
Many studies have confirmed that other kinds of situations, beyond passive viewing of an 
image or rest, can engage the default mode network in similar ways. For example, remembering 
the past (autobiographical memory), envisioning future events (prospection), considering the 
thoughts and perspectives of other people (theory of mind), and moral decision making all 
activate multiple regions within the DMN (Andrews-Hanna, 2012; Andrews-Hanna et al., 2010; 
Spreng & Grady, 2010; Buckner et al., 2008).  
The two most clearly defined regions within the DMN that play a role in these situations 
are the PCC and MPFC (Andrews-Hanna et al., 2010; Broyd et al., 2010) The PCC has been 
shown to be the only DMN region that directly interacts with all other DMN regions during 
working memory tasks, which suggests that it may play a pivotal role in how intrinsic activity is 
mediated throughout the DMN. The PCC is also a key region in cognitive tasks that touch upon 
various aspects of self-processing (Andrews-Hanna et al., 2010; Fransson & Marrelec, 2008; 
Leech, Braga, & Sharp, 2013; Leech & Sharp, 2013). The MPFC has been associated with social 
cognition involving the monitoring of the psychological state of oneself, as well as mentalising 
about the psychological state of others (Andrews-Hanna et al., 2010; Broyd et al., 2009; Mars et 
al., 2012). 
At present, the majority of RS fMRI assessment has been focused primarily on the DMN. 
Analysis of RS fMRI data, however, has suggested the existence of three other networks that 
play a significant role in other cognitive processes as well (Bressler & Menon, 2010; 
Damoiseaux et al., 2006; Raichle, 2011; Spreng, Sepulchre, Turner, Stevens, & Schacter, 2012).  
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The first network is the dorsal attention network (DAN), which is comprised of the 
posterior and anterior intra parietal sulcus (IPS), frontal eye fields (FEF), and extrastriate visual 
areas such as the middle temporal area (MT+). The DAN appears to be involved in the goal-
driven attention orienting (top-down) process and is responsible for the preparation and selection 
of stimuli for responses (Corbetta & Shulman, 2002; Li et al., 2012). Its activity often increases 
after presentation of cues associated with the where, when, or to what participants should direct 
their attention (Fox, Corbetta, Snyder, Vincent, & Raichle, 2005 ).  
The second network is the central executive network (CEN), covering medial and lateral 
PFC areas such as the dorsolateral prefrontal cortex (dlPFC) and the anterior inferior parietal 
lobule (aIPL). The CEN is involved in higher-order cognitive control and typically shows 
activation during performance of higher-level externally-directed cognitive tasks, when the 
shows decreased deactivation (Bressler & Menon, 2010; Sridharan, Levitin, & Menon, 2008).  
The fourth network is the salience network (SN), which is comprised of the insula (INS) 
and the anterior cingulate cortex (ACC). The SN is believed to play a critical, causal role in 
switching between the CEN and DMN across cognitive paradigms and stimulus modalities 
(White, Joseph, Francis, & Liddell, 2010; Sridharan et al., 2008). It is important to recognise the 
CEN is often paired with SN in some studies, and this combination is often referred to as the 
fronto-parietal control network (FPCN; Niendam et al., 2012; Spreng et al., 2012; Vincent et al., 
2008).  
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1.4 Default Mode Network and Alzheimer’s disease 
 
The exploration of these functional RSN has also provided novel insights into psychiatric 
and neurological disorders. The most compelling of these is the link between impairment in the 
DMN and Alzheimer’s Disease (AD), where an association between failure to deactivate the 
DMN when engaging in tasks requiring working memory and attention to exogenous stimuli has 
been observed in AD patients (Broyd et al., 2009; Buckner et al., 2008; Hafkemeijer, Grond, & 
Rombouts, 2012). AD is a progressive dementia and is characterised by the formation of neuritic 
plaques and neurofibrillary tangles in the cortex, with the hallmark symptoms of memory loss, 
language difficulties, and impairments in executive function (Burns & Iliffe, 2009). 
The earliest evidence to suggest the impairment of the DMN in AD was a study by 
Minoshima et al. (1997), which showed that there is a consistent progressive reduction in glucose 
metabolism (hypometabolism) in the PCC. This hypometabolism correlated with mental status 
and dementia severity (Minoshima et al., 1997). Subsequent work showed that the patterns of 
hypometabolism included PCC as well as other regions of DMN such as the IPL and MPFC 
(Greicius, Srivastava, Reiss, & Menon, 2004; Buckner et al., 2005).  
 Structural atrophy in the brain of AD patients also coincides with specific brain regions 
of the DMN. Buckner et al., (2005) showed that atrophy is present even in patients at the earliest 
stages of AD, with the PCC and IPL showing prominent atrophy. As dementia progressed, the 
atrophy rates accelerated across these regions, confirming that the impairment in the DMN is 
significantly correlated with the severity in dementia.  
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    Functional fMRI changes within the DMN have been explored in various studies which 
showed that these impairments were consistent with the metabolic and structural changes. Based 
on the analysis of intrinsic activity correlations and task-induced deactivations, Lustig et al., 
(2003) showed that deactivation was attenuated significantly in AD patients compared to young 
adults and cognitively-normal older adults. Rombouts and colleagues (2005) also showed that 
task-induced deactivation was attenuated in older participants with MCI; signifying altered brain 
deactivation was already present in patients in the prodromal stage of dementia. Other work has 
shown that dysfunction in the DMN is also associated with those older people with MCI who 
then progress to AD (Petrella et al., 2011). 
 In summary, the DMN seems to be highly disrupted by AD, perhaps related to the high 
metabolism of DMN regions, particularly the PCC, as these regions appear to be particularly 
vulnerable to atrophy in AD patients (Buckner, 2008). A recent review by Jacobs, Radua, 
Luckman, & Sack (2013) also showed that the PCC is a central hub in AD (i.e destabilization of 
the PCC could cause disruptions in large-scale cognitive networks and lead to structural, 
functional, and metabolic deficits seen in AD). Brier et al. (2012) concluded that AD does not 
only affect the DMN, but the DAN and SN as well, with increasing AD severity positively 
correlating with decreasing FC between all regions of these networks. 
1.5 Default Mode Network and Parkinson’s disease 
 
As problems in the DMN appear to be tightly linked with AD, it is relevant to ask 
whether impairments in DMN are also apparent in other types of neurodegenerative disorders. 
DMN integrity in PD is one such condition of interest. In a recent study, Weintraub et al. (2012) 
found that the overall pattern of brain atrophy in AD were similar to the progression of cognitive 
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decline in patients with PD, which indicates that similar brain regions were affected in both 
disorders.  
It is possible then to infer that the PD will also affect the DMN. Several studies that 
utilize the fMRI support this suggestion. Van Eimeren, Monchi, Ballanger, and Strafella (2009) 
showed that unmedicated patients with mild to moderate PD demonstrated less deactivation of 
the PCC, as well as decreased functional connectivity (FC) with the vMPFC, relative to controls, 
indicating a failure to deactivate the frontal part of the DMN for PD patients. Tessitore et al. 
(2012) also showed cognitively unimpaired patients with PD have decreased FC of the right 
medial temporal lobe (MTL) and bilateral inferior parietal cortex (IPC) within the DMN, when 
compared with controls, which could suggest that there is an prodromal functional disruption of 
the DMN in PD. Another study report decreased FC of the dentate nucleus (DN) to DMN 
regions, in cognitively unimpaired PD patients, which implies disruptions in RS FC between the 
cerebellum and the DMN in PD (Liu et al., 2013). Rektorova, Krajcovicova, Marecek, & Mikl 
(2012) reported significant decreases of FC in the inferior frontal gyrus (IFG) with the PCC for 
PD participants with dementia (PD-D), as compared to PD and HC. 
1.6 Diffusion Tensor Imaging 
 
  It is evident that literature on DMN in PD populations is minimal. Therefore, it is a good 
opportunity to add to that knowledge and bring a unique contribution to the research of DMN in 
PD. As imaging data using fMRI were not available in patients given brain scans at the New 
Zealand Brain Research Institute (NZBRI), where the current study was conducted, diffusion 
tensor imaging (DTI) was utilized to evaluate the microstructural integrity of the nodal regions 
within the DMN and other RSNs in the current study, looking at PD patients who through 
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detailed neuropsychological testing and evaluation of everyday activities had been carefully 
classified as showing relatively normal cognition (PD-N), mild cognitive impairment (PD-MCI), 
or with dementia (PD-D). Structural integrity is often examined using grey matter concentration 
in T1 images, which only provides a crude analogue of structural changes. 
DTI is a powerful form of magnetic resonance imaging (MRI) contrast that enables 
quantification of the direction of diffusing water molecules within the entire brain volume to 
study microstructural white and grey matter integrity in neurodegenerative diseases and to 
visualize brain fiber connections via tractography (Le Bihan et al., 2001; Scherfler et al., 2011; 
Schuff, 2009). Multiple MRI images are taken that measure the ability of water to diffuse along 
different gradient directions. These measurements allow calculation of the diffusion tensor 
(angulate variation of diffusion), to derive fractional anisotropy (FA) that represent the local 
directional ‘strength’ of white matter, especially nerve bundles, and Mean Diffusivity (MD) that 
reflect the total magnitude of diffusion and hence, information of alterations in the cellular 
integrity of grey matter regions (Scherfler et al., 2011; Skudlarski et al., 2008). Generally, FA 
value decreases when there is microstructural pathology that reflect decreased coherence such as 
myelination defects in the fiber tract and MD value increases when there is an increase in 
extracellular space as a result of fiber loss (Chua et al., 2009 Meijer, Bloem, Mahlknecht, Seppi, 
& Goraj, 2013).  
An example of the utilization of DTI in evaluating the DMN is a study by Teipel et al. 
(2010) that investigated the structural basis of the FC pattern for the DMN. White matter 
microstructure underlying default mode connectivity was evaluated by deriving FA values of 
fibre tract integrity DTI and RS-fMRI data from twenty healthy elderly participants (50 – 83 
years of age). The results of this study revealed that the functional connectivity between the PCC 
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and hippocampus from the RS- fMRI data was associated with the FA values of the white matter 
network connecting the regions of the DMN.  
A hypothesis-driven approach based on the functional connectivity of PCC and a data-
driven Independent Component Analysis (ICA) approach without a priori selection of correlated 
regions was shown to include the key regions of the DMN in the RS- fMRI data. When the 
functional connectivity data between PCC and hippocampus were regressed on the FA maps of 
white matter microstructure, distinctive subcortical white matter areas were found to match the 
distribution of DMN components. These structural problems of connectivity coincided with 
fMRI functional connectivity, supporting the value of using structured integrity to evaluate this 
network, and by extension, other RSN (Teipel et al., 2010). The findings of this study suggests 
that DTI is a useful and powerful tool that can be utilized to provide unique information about 
the microstructural changes that can occur in neurodegenerative disease such as Parkinson’s 
disease (Meijer et al., 2013; Schuff, 2009).   
Several studies on PD have shown that DTI is effective at imaging other brain correlates 
of PD, but not RSNs. However, it has been instructive in showing that DTI is sensitive to 
changes in PD. Matsui et al. (2007) showed that PD patients possess significant FA reduction in 
frontal, temporal and occipital white matter compared to controls. Moreover, patients with PD-D 
showed a significant reduction in bilateral posterior cingulate bundles compared to PD patients 
who are cognitively normal, which is consistent with the hypotheses in the current project. 
Another study by Chan et al. (2007) showed that the thalamus, globus pallidus, putamen, and 
caudate are relatively spared in PD patients who are cognitively normal, with unaltered MD and 
FA values in these regions. However, the FA value in the substantia nigra of these patients was 
lower compared to HC. The clinical severity of PD was also found to be correlated inversely 
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with the FA value in the substantia nigra of these patients. A subsequent study by Gattellaro et 
al. (2009) reported similar findings with decreased FA and increased MD in the substantial nigra, 
genu of the corpus callosum, and the superior longitudinal fasciculus, indicating degeneration in 
temporal and parietal areas of the brain in patients with PD who are cognitively normal.  
1.7 The Current Study 
 
The current study investigated the microstructural integrity of the DMN, as well as three 
other key cognitive RSNs, the DAN, SN, and CEN, based on DTI obtained in three separate 
groups of patients with PD. One group of patients (PD-N) were cognitively normal, while the 
second group of patients (PD-MCI) reflect the transitional phase of mild cognitive impairment 
prior to dementia, and the third group of patients (PD-D) possessed a clear diagnosis of 
dementia. A comparison group of healthy controls (HC) were included, matched across the three 
patient groups. The diffusion tensor images used in this study were previously discussed in a 
PhD study, ‘Magnetic resonance imaging of cognition in Parkinson’s disease’, by Melzer (2011). 
That thesis focused on whole-brain analysis in patients with PD and did not include evaluation of 
the RSN in the brain.  
The current study made a novel contribution by examining the microstructural integrity 
of the ROIs within each RSN, by evaluating the FA and MD values for the grey matter voxels in 
key nodes of the ROIs of these 4 RSNs. One important contribution of the current study was to 
assess the wider literature to identify the consistent coordinates of the key nodes within each 
RSN. The RSNs from the relevant past studies were evaluated to derive the coordinates of the 
ROIs in Montreal Neurological Institute (MNI) space (Friston et al., 1999) or Talairach space 
 
13 | P a g e  
 
(Turkeltaub et al. 2002) and these coordinates used to derive DTI metrics in nodes within the 
unique subject space for each individual. 
     It was expected that there would be minor if any changes in structural integrity of the 
RSNs for the PD-N group, relative to HC group. Changes in the structural integrity in the PD-
MCI group across the RSNs were expected to be similar to approach the structural integrity of 
the PD-D group, relative to HC and PD-N. The structural integrity of the PD-D group across the 
RSNs was expected to show loss of integrity, especially for the DMN. 
 
2. METHOD 
2.1 Participants 
 
A convenience sample of 118 patients meeting the United Kingdom Parkinson’s Disease 
Society’s criteria for idiopathic PD (Hughes, Daniel, Kilford, & Lees, 1992) were recruited from 
the Movement Disorders Clinic at the New Zealand Brain Research Institute, formerly known as 
the Van Der Veer Institute for Parkinson’s and Brain Research, Christchurch, New Zealand, 
from May 2007 to March 2010. Patients were diagnosed with probable PD by a neurologist who 
specialized in movement disorders. The Unified Parkinson’s Disease Rating Scale (UPDRS; part 
III, motor, Gancher, 2006), with Hoehn and Yahr staging (Hoehn & Yahr, 1967) was used to 
assess disease severity in terms of motor function for participants with PD. Individuals who 
represented the full spectrum of cognitive status in PD were invited to participate. The control 
group comprised of 38 healthy volunteers responding to community advertisements, who 
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reported no subjective cognitive problems on interview, matched to the entire PD sample in 
terms of the mean age, years of education, and sex ratio.  
General exclusion criteria included atypical parkinsonian disorders, history of other 
neurological or central nervous system disorders (e.g. moderate to severe head injury, stroke, 
vascular dementia), and major psychiatric or medical illness in the last 6 months. 
Neuroradiological screening after an MRI brain scan excluded four patients with PD and one 
control due to moderate-severe white matter disease, one patient with PD due to extensive 
cerebral atrophy, and one healthy control with severe cerebellar infarct. A further four PD 
patients and one control were excluded because of excessive motion (due to tremors while in the 
MRI scanner) or extreme susceptibility artifacts (which produce inconsistent and blurry MRI 
images). Four controls met the criteria for MCI and were excluded. Analyses were then 
conducted on the remaining 110 PD patients and 31 control subjects (Table 1). 
All participants gave informed consent, with additional consent from a significant other 
for dementia patients when required. The Upper South Regional Ethics Committee of the New 
Zealand Ministry of Health approved the study. 
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Table 1  
     
Demographic and clinical details for each group 
 
  Controls PD-N PD-MCI PD-D N-K Analysis (adjacent pairwise) 
      
n 31 64 28 18 
 
Age* 69.4 (8.9) 64.4 (8.6) 70.4 (7.6) 74 (6.8) HC = PD-N = PD-MCI <PD-D 
Sex (male : female) (23 : 8) (42 : 22) (19 : 9) (16 : 2) NS 
Education (years) 13.3 (2.9) 13.3 (2.9) 13.2 (3.4) 12.4 (2.5) NS 
MMSE* 28.4 (1.6) 28.3 (1.6) 26.1 (2.0) 22.9 (3.1) (HC = PD-N) <PD-MCI <PD-D 
MoCA* 27.0 (2.0) 26.7 (2.2) 22.9 (2.4) 16.4 (4.0) (HC = PD-N) <PD-MCI <PD-D 
Global Cognitive Z Score* 0.54 (0.38) 0.16 (0.42) -0.83 (0.39) -1.88 (0.51) HC <PD-N <PD-MCI <PD-D 
Domain Z Score¹ 
     
Executive Function* 0.60 (0.53) 0.37 (0.61) -0.90 (0.79) -2.06 (0.5) (HC = PD-N) <PD-MCI <PD-D 
Attention* 0.43 (0.46) 0.11 (0.48) -0.82 (0.57) -1.95 (0.60) HC <PD-N <PD-MCI <PD-D 
Learning and Memory* 0.91 (0.77) 0.30 (0.81) -0.73 (0.63) -1.7 (0.67) HC <PD-N <PD-MCI <PD-D 
     Visuospatial/Visuoperceptual* 0.21 (0.48) -0.14 (0.45) -0.87 (0.65) -1.87 (0.67) HC <PD-N <PD-MCI <PD-D 
            
Values are Mean (SD); group main effect, *p<.001; MMSE, Mini Mental State Examination; MoCA, Montreal Neurological Assessment; N-K, Newman-
Keuls; HC, Healthy Controls;  PD-N, cognitively unimpaired PD patients; PD-MCI, PD patients with Mild Cognitive Impairment; PD-D, PD patients with 
Dementia; NS, Not Significant. 
¹Language measures also contributed to a PD-MCI diagnosis, by using two scores of "fail" to indicate impairment within that domain because 
two of the three measures (Boston Naming Test; Similarities in the Dementia Rating Scale-2; language score in the ADAS-Cog) had strong 
ceiling effects in the controls that precluded the use of normative scores. 
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2.2 Neuropsychological and Neuropsychiatric Assessments 
 
Participants underwent comprehensive neuropsychological testing, that covered five 
cognitive domains, over two sessions. These cognitive domains were executive function, 
attention and working memory, learning and memory, visuospatial/visuoperceptual skills and 
language, consistent with the Movement Disorder Society (MDS) Task Force criteria for 
diagnosis of dementia (Dubois et al., 2007) or MCI (Litvan et al, 2012). 
Executive function was assessed using Action (verb) Fluency (Piatt, Fields, Paolo & 
Troster, 1999), Trails-Making Test Part B (TMT-B; Reitan, 1958; Arbuthnott & Frank, 
2000), and the Delis-Kaplan Executive Function System (D-KEFS; Delis, Kaplan, & Kramer, 
2001) Letter Fluency, Category Fluency, Category Switching, and Stroop Interference Test.
 Attention, working memory, and processing speed were evaluated using the Stroop 
Word and Colour Test in the D-KEFS (Delis et al., 2001), Digit Span Test-
Forward/Backword (Wechsler, 1997), Adaptive Digit Ordering Test (Werheid et al., 2002), 
Test Everyday Attention-Map Search (TEA-Map Search; Robertson, Ward, Ridgeway, & 
Nimmo-Smith, 1996), and Trails-Making Test Part A (TMT-A; Reitan, 1958).  
Learning and memory were measured using the free recall, short and long delay recall 
components of the California Verbal Learning Test-2 Short Form (CVLT-II SF; Delis, 
Kramer, Kaplan, & Ober, 2000) and the short and long delay recall of the Rey-Osterrieth 
Complex Figure (ROCF; Meyers & Meyers, 1995). Either short or long delay, but not both 
could indicate problems for each memory test. 
Visuospatial and visuoperceptual skills were assessed using the copy of the ROCF 
(Meyers & Meyers, 1995), Judgement of Line Orientation (JOL; Benton, Harnay, & Varney 
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(1975), and the fragmented letter task of the Visual Object and Space Perception Battery 
(VOS; Warrington & James, 1991). 
 Language was assessed using the Lansing Boston Naming Test (LBNT, short-form of 
the Boston Naming Task; Kaplan, Goodglass, & Weintraub, 1983; Lansing, Ivnik, Cullum, & 
Randolph, 1999), the Similarities subtest, identify which three items is different of the 
Conceptualization section of the Dementia Rating Scale-2 (DRS-2; Jurica, Leitten, & Mattis, 
2001), and the language items, ‘naming objects and fingers, verbal language/comprehension 
of spoken language, and word-finding’, of the Alzheimer Disease Assessment Scale – 
Cognitive subscale (ADAS-COG; Rosen, Mohs, & Davis, 1984; Lezak, 2004),. 
The Montreal Cognitive Assessment, Standardized Mini-Mental State Examination, 
Scales for Outcomes in Parkinson’s Disease-Cognition, and the Wechsler Test of Adult 
Reading (MoCA; Nasreddine, et al., 2005; SMMSE; Molloy & Standish, 1997; SCOPA-Cog; 
Marinus et al., 2003; WTAR; Holdnack, 2001) were also administered to assess their global 
cognitive abilities.  The MoCA is a brief cognitive screening tool that has been shown to be 
sensitive to subtle cognitive deficits in PD (Dalrymple-Alford et al., 2010; Chou et al., 2010). 
The SMMSE is a modified version of the MMSE (Folstein, Folstein, & McHugh, 1975) that 
has been found to be more reliable in screening elderly patients for cognitive impairment than 
the MMSE (Molloy, Alemayehu, & Roberts, 1991; Pangman, Sloan, & Guse, 2000; Vertesi 
et al., 2001). The SCOPA-Cog was developed as a PD-specific scale that focused on the 
cognitive deficits typically found in PD patients and recent studies have shown that it is a 
robust and reliable measure of cognitive function in PD, as well as possessing high validity in 
detecting MCI in PD populations (Forjaz, Frades-Payo, Rodriguez-Blazquez, Ayala, & 
Martinez-Martin, 2010; Isella et al., 2013, Kulisevsky & Pagonabarraga, 2009). The WTAR 
was normally used to assess premorbid intelligence, which assess reading irregular words that 
 
18 | P a g e  
 
are associated with intellectual functions thought to be resistant to cognitive decline as a 
result of the neurological damage in neurodegenerative disorders (Green et al., 2008). 
Neuropsychiatric status for all PD participants was evaluated with the 
Neuropsychiatric Inventory (NPI; Cummings et al., 1994), and the Geriatric Depression Scale 
(GDS; Yesavage et al., 1982). PD participants were also assessed for everyday functional 
activities relevant to dementia with the Functional Assessment Staging Tool, (FAST; 
Reisberg, 1988), the Activities of Daily Living  - International Scale (ADL-IS ; Reisberg et 
al., 2001), and the Global Deterioration Scale (GDS; Reisberg, Ferris, de Leon, & Crook, 
1982).  
The diagnosis of PD dementia (PD-D) was based on the criteria established by the 
MDS Task Force (Dubois et al., 2007), which states impairment (in research, 2 SD below 
normative data) in at least one measure in two or more cognitive domains, supported by 
evidence from the neuropsychological tests battery mentioned earlier (DRS-2 and ADAS-
COG; Jurica et al., 2001; Rosen et al., 1984) and the Clinical Dementia Rating (CDR; Morris, 
1993), along with evidence that the cognitive impairment is severe enough to affect everyday 
function as reported by a caregiver. 
The diagnosis of PD-MCI was based on criteria used at the NZBRI (Dalrymple-
Alford et al., 2011), 1.5SD:2 in a single domain (1.5SD below normative data for two 
measures in at least one of the cognitive domains). These criteria were consistent with the 
diagnostic criteria of the MDS Task Force for MCI (Litvan et al., 2012). No PD-MCI 
participants met the criteria for dementia (i.e. their cognitive impairments did not interfere 
significantly with everyday activities). No PD-N participants met the relevant criteria for PD-
MCI or PD dementia. 
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2.3 MRI Acquisition 
 
Imaging was conducted on a 3 tesla General Electric HDxt scanner (GE Healthcare, 
Waukesha, WI) with an 8-channel head coil. A 2-dimensional diffusion-weighted, spin-echo, 
echo planar imaging sequence was used to measure microstructural integrity, with diffusion 
weighting in 28 uniformly distributed directions (b = 1,000 s/mm²) and 4 acquisitions without 
diffusion weighting (b = 0 s/mm²): echo time (TE) / repetition time (TR) = 86.4/13,000 
milliseconds, flip angle = 90˚, acquisition matrix = 128 × 128 × 48, reconstruction matrix =  
256 × 256 × 48, field of view = 240 mm, slice thickness = 3 mm, and reconstructed voxel 
size = 1.07 × 1.07 × 3 mm³. Volumes were acquired without cardiac gating. A T1-weighted 
(spoiled gradient recalled echo; TE/TR = 2.8/6.6 milliseconds, inversion time = 400 
milliseconds, flip angle = 15˚, acquisition matrix = 256 × 256 × 170, field of view = 250 mm, 
slice thickness = 1 mm) and a T2-weighted, fluid-attenuated inversion recovery sequence 
(TE/TR = 105/9,000 milliseconds, inversion time = 2250 milliseconds, slice thickness 3 mm, 
gap = 1.5 mm) were also acquired. 
2.4 MRI Preprocessing 
 
Image preprocessing was performed using the FSL 4.1.6 (FMRIB Software Library, 
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/; Smith et al., 2004) and the SPM5 (Statistical Parametric 
Mapping version 5; http://www.fil.ion.ucl.ac.uk/spm/software/, Wellcome Department of 
Cognitive Neurology, University College London, UK) in MATLAB 7.6.0 (R2008a, 
Mathworks, MA, USA). Diffusion-weighted image were motion- and eddy current distortion-
corrected using registration and motion correction software in FSL. The diffusion tensor was 
calculated at each voxel using DTIFIT in FSL, producing fractional anisotropy (FA) and 
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mean diffusivity (MD) images. The mean b0 image (a volume without diffusion weighting) 
and other DTI images were then co-registered to the high-resolution, T1-weighted SPGR 
image in SPM5. Each T1-weighted image was segmented, modulated, and normalized to 
create grey matter, white matter, and CSF maps, by employing unified segmentation 
(Ashburner & Friston, 2005) with tissue priors from a probabilistic elderly brain template 
(Lemaitre, 2005). Normalization parameters produced during segmentation were then used to 
warp the FA and MD images into the standardized space of the elderly template. 
This study defined regions of interest (ROIs) in standard space (‘normalized space’ or 
‘MNI space’) that were then localized in subject (‘native’) space in each participant. The 
segmentation process produced two sets of parameters: normalization parameters, which are 
used to warp the image in subject space into normalized/standard space, and inverse 
normalization parameters, which were used to warp images in normalized/standard space 
back to subject space. After the ROIs were defined, the inverse normalization parameters 
were used to warp the ‘normalized’ ROIs into the subject space of each individual.  The mean 
FA/MD value was then extracted from each ROI for each individual and statistical analyses 
conducted on these values.  
2.5 Search Strategy 
 
Regions of interest (ROIs) in standard space for the four cognitive networks and their 
corresponding (x, y, z) coordinates were first defined by conducting a selective meta-analysis 
of all the relevant studies that evaluated one or more cognitive networks by searching the 
PubMed database. The search was conducted up to September 2012, from references 
beginning January 2005, as most significant papers on the cognitive networks were published 
after 2005. The following search terms were used: ‘default network’, ‘default mode network’, 
‘resting-state’, ‘resting-state network’, ‘dorsal attention’, ‘dorsal attention network’, ‘salience 
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network’, ‘central executive network’,  and ‘executive control network’. All papers included 
are in the English language. 
2.6 ROIs/Studies Selection Criteria 
 
Studies were included if they met the following criteria: (1) an original research paper 
in a peer-reviewed journal, (2) only evaluated participants with the age range of between 18 
to 100, except for meta-analytic studies that could cover a wider range of ages (3) clear 
labeling of each ROI and the cognitive brain network to which it belonged, and (4) provided 
MNI or Talairach coordinates for each ROI in each network. There were two exceptions to 
these criteria. Manual classification of the ROIs as belonging to a particular network in some 
studies were performed as the cognitive networks are often labeled under different names 
with the same underlying definitions (i.e. labelling the DMN as Task Negative Networks, 
with the other cognitive networks as Task Positive Networks, and the labeling of the SN and 
CEN are often classified as part of the same cognitive network in some studies) (Fox et al., 
2007; Gao & Lin, 2012). The second exception was the exclusion of the hippocampus as part 
of the DMN, as the hippocampus has been inconsistently associated with the DMN. 
      The ROIs for each network and their coordinates were then extracted from the 
selected studies based on three criteria: (1) ROIs that were consistently reported across 
studies for a particular cognitive network  were included as part of the network, (2) MNI or 
Talairach coordinates for each ROI were either generated from a healthy control group or 
mixed group (with healthy control group always present and another experimental group), (3) 
MNI or Talairach coordinates for each ROI were either similar to the coordinates for the 
same ROI in the same network in other studies. 
      All Talairach coordinates for the ROIs that were selected in the final analysis were 
converted to MNI, for the convenience of having a consistent measure for further coordinate 
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analysis, using a sub-function of the GingerALE software package (Ginger Activation 
Likelihood Estimation version 2.1.1; Eickhoff et al., 2009; http://www.brainmap.org/ale/), 
called the ‘tal2icbm’ transform function, an algorithm which has the ability to transform 
coordinates between MNI space and Talairach space. It is based on the Lancaster transform, 
an improved algorithm that substantially reduces Talairach to MNI conversion bias (Laird et 
al., 2007).  
2.7 Derivation of ROIs 
 
      Thirty-two studies that assessed one or more cognitive networks met the inclusion 
criteria. The recorded variables for each selected articles were: health status and mean age of 
participants, participant instructions (e.g. eyes closed/open or fixating on visual stimuli), how 
ROIs were derived (e.g. Functional Connectivity or Independent Component Analysis), ROIs 
of healthy control or mixed group, and the MNI coordinates for each ROI (Talairach 
coordinates were converted to MNI if used). Twenty-four studies were evaluated for the 
derivation of DMN ROI (Table 2), eight studies for DAN ROI (Table 3), and eight studies for 
SN/CEN ROI (Table 4). Abbreviations for the ROIs in these studies are provided in Table 5.
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Table 2 
  
 
Studies assessed to select the ROIs for DMN  
   
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
 
TNN 
 
 Fox et al. (2005) PCC (-1, -34, 40) (-2, -36, 37) 
Healthy Participants Retro-splenial (5, -52, 9) (3, -51, 8) 
Resting State (eyes closed/eyes open) lLPC (-49, -66, 49) (-47, -67, 36) 
Visual Stimuli (eyes fixated on crosshair) rLPC (58, -66, 41) (53, -67, 36) 
ROIs derived from FC of 3 seed regions referred as 
the Task Negative Network (TNN), so any regions 
that was active at the same time as the seed regions 
was chosen as DMN ROIs 
lMPFC (-2, 42, -10) (-3, 39, -2) 
Seed regions = MPFC, PCC/PCu, LPC rMPFC (2, 60, 14) (1, 54, 21) 
MPFC  = (-1, 47, -4) lSFG (-14, 46, 50)  (-14, 38, 52) 
PCC/PCu =  (-5, -49, 40) rSFG (20, 45, 50) (17, 37, 52) 
LPC =  (-45, -67, 36) lITC (-64, -35, -17) (-61, -33, -15) 
 
rITC (71, -18, -20)  (65, -17, -15) 
 
lPHG (-23, -28, -19) (-22, -26, -16) 
 
rPHG (28, -27, -18) (25, -26, -14) 
  Cerebellum (8, -58, -48) (7, -52, -44) 
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Table 2 (continued) 
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
 
TNN 
  Zhou et al. (2007) PCC/PCu (6 ,-54, 30) 
 Healthy Participants / Schizophrenia Patients ldMPFC (-3, 54, 6) 
 Healthy Controls - (Mean Age ± SD: 24 ± 3.9 ) rdMPFC (3, 51, 21) 
 Schizophrenia - (Mean Age ± SD: 24 ± 4.9 ) lLP (-42, -69, 33) 
 Resting State (eyes closed)  rLP (48, -57, 30) 
 ROIs derived from FC of seed region, so any regions 
that was active at the same time as the seed region 
was chosen as DMN ROIs  
lITG (-60, -6, -24) 
 Seed region for Task Negative Network (TNN) - 
PCC/PCu 
rITG (63, -3, -24) 
 
 
lPHG (-24, -21, -21) 
 
 
rPHG (27, -12, -30) 
   lMFG (-39, 12, 51)   
 
ROI selected from Resting State 
ICA   
Harrison et al. (2008) MeFG (-9, 57, 24) (-9, 56, 19) 
Healthy Participants IPL (-48, -57, 24) (-48, -54, 25) 
(Mean Age ± SD: 26 ± 3.5) PCG (-3, -57, 30) (-3, -54, 30) 
Resting State (eyes closed) IFG (45, 27, -21) (45, 25, -19) 
Moral Dilemma Task Cerebellum (-33, -78, -37) (-33, -77, -27) 
Stroop Task ITG (-57, -9, -24) (-56, -10, -20) 
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ROIs derived from ICA with ICs spatially correlated 
to a-priori constructed DMN template 
IFG (-40, 33, -14)           (-40, 31, -13)            
ICs which have the highest correlation to the ROIs 
in the template was selected as DMN ROIs 
PHG (-37, -7, -19) (-37, -8, -16) 
Self-developed DMN template       
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
   
 
 
MPFC (-6, 20, -14) 
 
Scheeringa et al. (2008) lIFG (-48, 30, -14) 
 
Healthy Participants rIFG (38, 44, -18) 
 
Young Adult / Adult (18 -28) lMTG (-62, -2, -24) 
 
Visual Stimuli (eyes fixated on crosshair) lCerebellum (-28, -88, -34) 
 
ROIs derived from negative correlation with EEG 
frontal theta value 
lIPL/AG (-42, -68, 28) 
 
EEG frontal theta activity = EEG index for DMN rIPL/AG (46, -64, 36) 
 
 
rCerebellum (26, -90, -32) 
 
 
rMTG (70, -32, -8) 
 
 
rMTG (64, -16, -18) 
 
  rPCu/ACC (2, -60, 38)   
 
ROI from ICA of HC group 
  
Mohammadi et al. (2009) vACC/MPFC/OFC (-2, 41, 29) (-3, 35, 33) 
Healthy Participants PCC (-4, -53, 24) (-5, -53, 21) 
Amyotrophic lateral sclerosis (ALS) Patients rIPC (50, -57, 28) (45, -57, 25) 
Middle Age / Elderly (48 - 69) lIPC (-46, -60, 31) (-44, -60, 26) 
Resting State (eyes closed) rTG (54, 2, -22) (50, 2, -15) 
ROI derived from ICA lTG (-53, 1, -17)  (-50, 1, -12) 
 
26 | P a g e  
 
 
 
 
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
 
ROI from FC of HC group 
  Bluhm et al. (2009) PCC/PCu (0, -56, 0) 
 Healthy Participants MPFG (-2, 68, 12) 
 Depressed Patients lAG (-50, -60, 30) 
 Young Adult / Adult (17 - 35) lMFG (-24, 32, 48) 
 Resting State (eyes closed) rCH (12, 12, 4) 
 ROIs derived from FC of seed region, so any regions 
that was active at the same time as the seed region 
was chosen as DMN ROIs 
rSFG (26, 38, 46) 
 Seed region = PCC/PCu (0, -56, 20)  lCB (-12, 4, 16) 
 
 
lThalamus (-20, -16, 10) 
   rMeFG (6, 38, 24)   
 
ROI from FC of HC group 
  Boly et al. (2009) PCC/PCu (2, -56, 30) 
 Healthy Participants MPFC/STS (2, 62, -2) 
 Vegetative State / Brain Dead Patients lTPJ (-48, -66, 48) 
  (Mean Age ± SD: 41 ± 11, Range: 26 - 54 yrs.) rTPJ (62, -58, 28) 
 Resting State (eyes closed) lPHG (-24, -34, -28) 
 ROIs derived from FC of seed region, so any regions 
that was active at the same time as the seed region 
was chosen as DMN ROIs 
Temporal Cortex (54, -10, -30) 
 
ROIs determined with visual inspection based on 
their anatomical distribution and comparisons with 
prior literature. 
rPHG (24, -18, -16) (21, -17, -12) 
 
lPHG (-21, -17, -14) (-21, -16, -10) 
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Seed region = PCC (-5, -49, 40)  Medial Thalamus (-8, -16, 10)   
   
 
Schöpf et al. (2010) lPCu (-2, -56, 28) 
 
Healthy Participants rAG (50, -70, 34) 
 
(Mean Age ± SD: 27.3 ± 7.1) lAG (-48, -60, 36) 
 
Resting State (eyes closed) lMTG (-60, -14, -22) 
 
ROIs derived from FENICA rIFG (42, 20, 14) 
 
FENICA - new method of ICA analysis that does not 
require a priori template or visual inspection 
      
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
 
Mean of 3 test-retest sessions 
 
 
Meindl et al. (2010) ACC (0, 54, 7) 
 
Healthy Participants PCC (-1, -54, 27) 
 
Young Adult / Adult (23 - 36) rIPL (48, -60, 29) 
 
Resting State (eyes closed) lIPL (-42, -67, 31) 
 
ROIs derived from ICA rSFG (24, 38, 44) 
 
ROIs derived from ICA with ICs confirmed as DMN 
components if co-activations of PCC, ACC, IPL were 
found 
lSFG (-22, 37, 45)   
 
ROI from ICA of HC group 
  
Wu et al. (2011)  PCC (3, -53, 16) (3, -51, 17) 
Healthy  lIPC  (-49, -60, 31) (-48, -57, 31) 
Alzheimer's Disease (AD) MPFC (3, 46, 16) (3, 45, 12) 
Middle-age / Elderly (53 - 79) rIPC (54, -60, 28) (53, -57, 29) 
Resting State (eyes closed) rITC (63, -6, -19) (62, -7, -16) 
ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DMN template 
lITC (-60, -12, -16) (-59, -12, -13) 
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 ICs which have the highest correlation to the ROIs in 
the template was selected as DMN ROIs 
lHC (-30, -34, -8)         (-30, -33, -5)         
Template from previous studies rHC (24, -22, -12) (24, -22, - 9) Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if
present 
 
ROI from ICA of HC group 
  
Liao et al. (2011) PCC/PCu (-6, -54, 36) 
 
Healthy Participants lIPL (-42, -66, 33) 
 
Mesial Temporal Lobe Epilepsy Patients rIPL (54, - 63, 36)  
 
Young Adult / Adult / Middle Age (18 -51) lMesTL (-21, -15, -27) 
 
Resting State (eyes closed) rMesTL (24, -9, -21) 
 
ROIs derived from ICA with ICs spatially correlated 
to a-priori constructed DMN template 
lITG (-60, -12, -21) 
 
ICs which have the highest correlation to the ROIs 
in the template was selected as DMN ROIs 
rITG (60, -3, -27) 
 
Template from previous studies MPFC (0, 54, -6)   
   
 
 
PCu (1, -64, 43) 
 
Allen et al. (2011) PCC (0, -52, 22) 
 
Healthy Participants lAG (-43, -69, 33) 
 
Participants from meta-analysis of 34 studies so age 
varies from adolescence to elderly (Mean Age ± SD: 
23.4 ± 9.2, Range: 12 - 71 yrs.) 
rAG (47, -66, 32) 
 
Visual Stimuli (eyes fixated on crosshair) MeFG (-1, 45, -9) 
 
ROIs derived from ICA ACC (0, 41, 4) 
 
 
MCC (1, -30, 41) 
 
 
rIFG (32, 22, -15) 
 
 
rMFG (40, 43, 8) 
 
 
lMFG (-26, 26, 42) 
 
 
rMFG (26, 33, 41) 
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  MCC (0, 21, 40)   
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    Camchong et al. (2011) PCC/PCu (1, -57, 31) 
 
Healthy Participants PCC/CG (1, -18, 36) 
 
Schizophrenia Patients ACG (1, 38, 12) 
 
Healthy Controls - (Mean Age ± SD: 41.1 ± 10.6) rPL (42, -54, 36) 
 
Schizophrenia - (Mean Age ± SD: 41.3 ± 9.8) lPL (-34, -62, 36) 
 
Resting State (eyes closed) rCG (2, 14, 36) 
 
ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DMN template 
lIFG (-42, 14, 28) 
 
ICs which have the highest correlation to the ROIs in 
the template was selected as DMN ROIs 
rMFG (22, 58, -4) 
 
Template based on previous studies. lMFG (-26, 54, 0) 
 
 
rMTG (50, -50, 16) 
 
 
lMTG (-50, -50, 16) 
 
 
rThalamus (10, -18, 8) 
 
  lThalamus (-6, -14, 4)   
    
Li et al. (2011) PCC (6, -49, 25) 
 
Healthy Participants MPFC (-12, 62, 8) 
 
(Mean Age ± SD: 21 ± 3.4) lIPC (-43, -67, 33) 
 
Resting State (eyes closed) rIPC (45, -60, 29) 
 
ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DMN template 
lInferoTC (-59, -15, -16) 
 
ICs which have the highest correlation to the ROIs in 
the template was selected as DMN ROIs 
rInferoTC (59, -12, -20) 
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 Template based on literature review of DMN in article  lHippocampus (-22, -15, -22) 
 
  rHippocampus (25, -15, -23)   
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
      
 
 
PC-VP (6, -51, 33) (4, -52, 29) 
 
lPHG (-24, -24, -21 (-23, -22, -17) 
 
rPHG (24, -22, -21) (21, -20, -16) 
 
rAG (51, -61, 30) (46, -61, 26) 
 
lAG (-51, -63, 31) (-49, -63, 25) 
Tomasi & Volkow (2011) MeFG (0, 57, 16) (-1, 50, 23) 
Healthy Participants - meta-analysis of various studies SFG (24, 36, 51) (21, 27, 53) 
Young Adult / Adult / Middle Age / Elderly (18 - 71) ACG (0, 54, -5) (-1, 49, 4)  
Resting State  MTG (60, -10, -22) (55, -9, -15) 
ROIs derived from FC of hub region : PC-VP, so any 
regions that was active at the same time as the seed 
region was chosen as DMN ROIs 
MTG (63, -33, -6) (57, -32, 3) 
 
rIFG (33, 18, -24) (30, 17, -15) 
 
lIFG (-30, 12, -24) (-28, 12, -17) 
 
ITG (-60, -12, -21) (-56, -11, -17) 
 
STG (-39, 18, -33) (-37, 18, -24) 
 
Cerebellum (Semilunar lobule)  (-31, -81, -36) (-29, -74, -36) 
 
Brainstem (Medulla) (-6, -54, -45) (-6, -48, -41) 
 
Brainstem (Medulla) (6, -51, -48) (5, -45, -43) 
 
Cerebellum  (24, -85, -30) (21, -78, -30) 
 
Cerebellum (Semilunar lobule) (39, -75, -39) (35, -68, -37) 
 
IFG (42, 33, -18) (38, 30, 8) 
 
Brainstem (Midbrain) (0, -15, -18)  (-1, -14, -13) 
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Brainstem (Pons) (0, -21, -27) (-1, -19, -22) 
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    
 
aMPFC (-3, 57, 21) 
 
Song et al. (2011) lSFC (-12, 45, 48) 
 
Healthy Participants rSFC (21, 42, 48) 
 
Generalized Tonic-Clonic Seizures Epilepsy Patients vACC (-3, 36, -6) 
 
Control - (Mean Age ± SD: 27.1 ± 4.5) lITC (-54, -3, -30) 
 
GTCS Patients - (Mean Age ± SD: 26.1 ± 6.1) rITC (54, 0, -30) 
 
Pre-defined ROIs selected from previous studies lPHG (-24, -18, -27) 
 
 
rPHG (24, -12, -27) 
 
 
PCC (-3, -45, 33) 
 
 
Rsp (-15, -54, -6) 
 
 
lLPC (-54, -69, 36) 
 
 
rLPC (54, -63, 33) 
 
  CT (9, -51, -45)   
    Yeo et al. (2011) MFG (-27, 23, 48) 
 Healthy Participants lAG (-41, -60, 29) 
 Young Adult / Adult (18 - 35) lMTG (-64, -20, -9) 
 Resting State (eyes closed) dMPFC (-7, 49, 18) 
 Resting State (eyes open) lPHG (-25, -32, -18) 
 Visual Stimuli (eyes fixated on crosshair) PCu (-7, -52, 26) 
 ROIs derived from FC of seed regions to the right, so 
any regions that was active at the same time as the seed 
regions was chosen as DMN ROIs 
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Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    
Koch et al. (2012) ACC (1, 50, 11)  (0, 45, 17) 
Healthy Participants  PCC (0, -53, 25) (-2, - 53, 22) 
Mild Cognitive Impairment (MCI) Patients lLPC (-44, -67, 24) (-43, -66, 20) 
Alzheimer's Disease (AD) Patients rLPC (50, -62, 19) (45, -61, 17) 
Elderly (57 - 100) lSFG (-20, 26, 52) (-20, 19, 52) 
Resting State (eyes closed) rSFG (28, 24, 51)  (25, 17, 51) 
ROIs derived from visually analyzing the ICA data and 
selecting the regions which has DMN co-activation 
patterns 
lMTC (-60, -12, -12) (-57, -11, -9) 
 
rMTC (58, -7, -16)) (53, -7, -11) 
 
lHippocampus (-21, -15, -13) (-21, -16, -14) 
  rHippocampus (24, -20, -16) (21, -19, -12) 
   
 
Gao & Lin (2012)  lHF (-21, -15, -14) 
 
Healthy Participants rHF (24, -19, -21) 
 
Adult (25 - 33) vMPFC (0, 51, -7) 
 
RS (eyes closed) PCC (1, -55, 17) 
 
FT (finger tapping) lpIPL (-47, -71, 29) 
 
MW (movie watching) rpIPL (50, -64, 27)  
 
Pre-defined ROIs selected from Vincent et al. 2008 
   
 
      
 
 
 
33 | P a g e  
 
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    Qi et al. (2012) 
   Healthy Participants 
   Minimal Hepatic Encephalopathy (mHE) Patients lAG (-33, -76, 40) 
 
Control - (Mean Age ± SD: 55 ± 9.5) rAG (51, -70, 43) 
 mHE Patients - (Mean Age ± SD: 56.6 ± 9.1) rACC (6, 41, 19) 
 
Resting State (eyes closed) lPHG (-30, -40, -13) 
 
ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DMN template 
rPHG (27, -34, -13) 
 ICs which have the highest correlation to the ROIs in 
the template was selected as DMN ROIs 
PCC/PCu (0, -43, 40) 
 
Template based on previous studies 
   
 
   
 
      
    Wang et al. (2012) 
  
 
Healthy Participants MPFC (12, 54, 0) 
 
Generalized tonic-clonic seizures (GTCS) Patients vACC (0, 27, 18) 
 
Healthy - (Mean Age ± SD: 27.9 ± 8.4) PCu (-9, -51, 51) 
 
GTCS - (Mean Age ± SD: 27.4 ± 4.5) rAG (48, -72, 33) 
 
Resting State (eyes closed) PCC/Rsp (-9, -42, 3) 
 
ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DMN template 
lLTC (-57, -3, -24) 
 ICs which have the highest correlation to the ROIs in 
the template was selected as DMN ROIs 
   DMN template from previous studies       
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Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    Liu et al. (2012) ROI from ICA of HC group 
  
Healthy Participants AG (-51, -68, 40)                                 (-49, -68, 33)                                 
Alzheimer's Disease (AD)Patients CG (-7, -43, 39) (-8, -45, 35) 
Control - Adult / Elderly (49 - 78) IPL (-50, -61, 45) (-48, -62, 38) 
AD patients - Adult / Elderly (43 - 76) MTG (-51, -63, 35) (-49, -63, 29) 
Resting State (eyes closed) PCC/PCu (0, -50, 44) (-2, -52, 39) 
ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DMN template 
SPL (-39, -66, 52) (-38, -68, 44) 
ICs which have the highest correlation to the ROIs in 
the template was selected as DMN ROIs 
STG (-53, 58, 35) (-51, -59, 29) 
Template based on previous studies Supramarginal (65, -52, 27) (59, -53, 25) 
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Table 2 (continued) 
 
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    
 
Precuneus (6, -63, 24) 
 De Vogelaere et al. (2012) lAG (-51, -69, 24) 
 Healthy Participants rAG (51, -66, 24) 
 Mild Cognitive Impairment (MCI) Patients lMTG (-63, -15, -15) 
 Healthy - (Mean Age ± SD: 62.1 ± 7.8) rMTG (66, -12, -9) 
 MCI - (Mean Age ± SD: 67.2 ± 7.9) ACG (-6, 42, 18) 
 Resting State (eyes closed) Thalamus (6, -18, 12) 
 ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DMN template 
lRO (-45, -12, 18) 
 ICs which have the highest correlation to the ROIs in 
the template was selected as DMN ROIs 
lHippocampus (-24, -15, -12) 
 DMN template from GIFT (Group ICA of fMRI 
Toolbox, available at 
http://mialab.mrn.org/software/gift/) 
rHippocampus (27, -12, -18) 
 
 
lPostcentral Gyrus (-30, -33, 51) 
 
 
lIFG (-51, 15, 33) 
   rSTG (42, -33, 18)   
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Table 2 (continued) 
 
Article DMN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    Jin et al. (2012) lLPFC (-26, 18, 60) 
 
Healthy  rLPFC (26, 30, 26) 
 
amnestic Mild Cognitive Impairment (aMCI) lHC (-30, -12, -22) 
 
Healthy - (Mean Age ± SD: 60.63 ± 8.3) lPHG (-30, -26, -20) 
 
aMCI - (Mean Age ± SD: 60.88 ± 3.22) lFG (-32, -26, -18) 
 
RS (eyes closed) PCC/Rsp/Precuneus (-6, -60, 22) 
 
ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DMN template 
lMTG (-54, 4, -12) 
 
ICs which have the highest correlation to the ROIs in 
the template was selected as DMN ROIs 
rAG (48, -72, 30) 
 
DMN template from GIFT (Group ICA of fMRI 
Toolbox, available at 
http://mialab.mrn.org/software/gift/) 
MPFC (8, 46, 36) 
 
 
lIPL (-46, -42, 54) 
 
 
lMCC (-20, -30, 26) 
 
  rMCC (4, -28, 36)   
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Table 3 
   
Studies assessed to select  the ROIs for DAN  
   
Article DAN  
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
  
 
 Fox et al. (2005) lIPS (-23, -65, 53) (-23, -66, 46) 
Healthy Participants rIPS (29, -56, 58) (25, -58, 52) 
Resting State (eyes closed/eyes open) lIPL (-43, -41, 55) (-42, -44, 49) 
Visual Stimuli (eyes fixated on crosshair) rIPL (52, -33, 56)  (47, -37, 52) 
ROIs derived from FC of 3 seed regions referred as the 
Task Positive Network (TPN), so any regions that was 
active at the same time as the seed regions was chosen as 
DAN ROIs 
lvIPS (-26, -81, 32) (-26, -80, 26) 
Seed regions =  IPS, FEF, MT+ rvIPS (39, -82, 35)  (35, -81, 29) 
IPS = (-25, -57, -46) lFEF (-24, -7, 65) (-24, -12, 61) 
FEF = (25, -13, 50) rFEF (32, -1, 56) (28, -7, 54) 
MT+ = (-45, -69, -2) IPCeS (59, 5, 34) (54, 0, 35) 
 
lMT+ (-49, -72, -1)  (-47, -69, -3) 
  rMT+ (59, -69, -2)  (54, -63, -8) 
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Table 3 (continued) 
Article DAN  
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
    
 
rFEF (32, -5, 55) (28, -10, 53) 
Fox et al. (2006) lFEF (-25, -7, 58)  (-25, -12, 55) 
Healthy Participants rpIPS (23, -65, 58) (20, -67, 51) 
Resting State (eyes closed/eyes open) lpIPS (-22, -67, 53) (-22, -68, 46) 
Visual Stimuli (eyes fixated on crosshair) raIPS (39, -45, 49) (35, -47, 45) 
ROIs derived from FC of 3 seed regions referred as 
the Task Positive Network (TPN), so any regions 
that was active at the same time as the seed regions 
was chosen as DAN ROIs 
laIPS (-43, -39, 46) (-42, -41, 43) 
Seed regions identified through meta-analysis of 
prior studies 
lSMA/pre-SMA (-3, 5, 55) (-4, -1, 53) 
Seed regions =  IPS, FEF rIFG (57, 10, 25) (52, 6, 27) 
rIPS  = (27, -58, 49) rMT+ (56, -66, -7) (51, -63, -7) 
rFEF  = (24, -13, 51) lMT+ (-48, -72, -5)) (-46, -68, -7) 
 
rMFG (41, 43, 14)) (37, 38, 20) 
 rINS (33, 20, 4) (30, 17, 9) 
    Zhou et al. (2007) TPN 
  Healthy Participants / Schizophrenia Patients rIFG (54, 12, 21) 204 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) lIFG (-51, 9, 27) 130 
Resting State (eyes closed) rMT+ (44, -64, -12) 121 
ROIs derived from FC of seed region  lMT+ (-51, -57, -12) 175 
Seed region for TPN - rDPLFC lCPL (-12, -75, -27) 21 
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Table 3 (continued) 
 
Article DAN  
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
    
 
MFG (40, 36, 20) 
 
 
lINS (-40, 16, 0) 
 Grady et al. (2010) rINS (36, 16, -8) 
 Healthy Participants lFEF (-32, -8, 56) 
 Young Adult / Elderly  rFEF (28, -4, 48) 
 Age Range - (20 - 30, 56 - 84) lPreCG (-56, 8, 28) 
 Visual Stimuli - various visual stimulus rPreCG (48, 4, 24) 
 Visual Tasks rSUPPMA (4, -4, 56) 
 ROIs was derived from Visual Tasks lIPL (-48, -40, 40) 
 Brain regions showing more activity for Visual Stimuli = 
selected as DAN ROIs 
rIPL (44, -44, 44) 
 
 
lIPS (-28, -60, 56) 
 
 
rIPS (28, -60, 48) 
 
 
lIOG (-48, -72, -4) 
 
 
rMOG (28, -72, 28) 
 
 
rFusiform Gyrus (44, -64, -12) 
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Table 3 (continued) 
Article DAN  
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
    Li et al. (2012) 
   Healthy participants / AD patients lIPS (ls/ipl) (-39, -63, 56) 
 
Middle-age / Elderly (53 - 79) rIPS (rs/ipl) (42, -51, 52)   
 
Resting State (eyes closed) lFEF (lm/ifg) (-39, 51, 8) 
 
ROIs derived from ICA with ICs spatially correlated to a-
priori constructed DAN template 
rFEF (rmfg) (33, 18, 56)        
 
ICs which have the highest correlation to the ROIs in the 
template was selected as DAN ROIs 
lFEF (lm/sfg,cg)  (-6, 24, 44)        
 
Template based on past studies 
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Table 3 (continued) 
Article DAN  
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
    Liu et al. (2012) 
 
  
Healthy Participants 
   Minimal Hepatic Encephalopathy (mHE) Patients IPL (43, -48, 62) (38, -52, 56) 
Elderly (55 - 67) MOG (56, -66, -10) (51, -63, -10) 
Resting State (eyes closed) MTG (61, -58, -10) (55, -55, -9) 
ROIs derived from ICA with ICs spatially correlated to 
a-priori constructed DAN template 
SOG (-31, -83, 33)  (-30, -82, 26) 
ICs which have the highest correlation to the ROIs in 
the template was selected as DAN ROIs 
SPL (30, -60, 65) (26, -63, 57) 
Template based on previous studies 
   
 
   
 
           
    Gao & Lin (2012)  
   Healthy Participants lMT+ (-45, -69, -2) 
 Adult (25 - 33) rMT+ (50, -69, -3) 
 Resting State (eyes closed) lIPS (-27, -52, 57)  
 Finger Tapping Task rIPS (24, -56, 55) 
 Movie Watching lFEF (-25, -8, 50)  
 Pre-defined ROI selected from Vincent et al. 2008 rFEF (27, -8, 50) 
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Table 3 (continued) 
 
Article DAN  
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
    Fornito et al. (2012) 
   Healthy Participants lIPS (-27, -69, 39) 
 Adults (19 - 36) rIPS (33, -45, 48)   
 Memory Task  rpSTS (51, -42, 15) 
 ROIs derived from ICA with ICs spatially correlated to a-
priori constructed DAN template 
lFEF (-48, 6, 30)        
 ICs which have the highest correlation to the ROIs in the 
template was selected as DAN ROIs 
ldPreCS  (-27, -6, 63)        
 
ROI determined with visual inspection based on their 
anatomical distribution and derived from prior literature  
lCuneus  (-12, -102, 3)        
 
 
           
 
 
 
 
43 | P a g e  
 
 
 
Table 4 
   Studies assessed to select the ROIs for SN/CEN 
   
Article 
SN 
(bold)/CEN(italics)  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
  
 
 Fox et al. (2005) 
   Healthy Participants SMA/pre-SMA (-1, 7, 52)  (-2, 1, 51) 
Resting State (eyes closed/eyes open) laINS (-47, 7, 5) (-45, 5, 8) 
Visual Stimuli (eyes fixated on crosshair) raINS (49, 7, 10) (45, 4, 14) 
ROIs derived from FC of 3 seed regions referred as the Task 
Negative Network (TPN), so any regions that was active at the same 
time as the seed regions was chosen as SN ROIs 
ldlPFC (-44, 45, 21)  (-40, 39, 26) 
Seed regions = MPF, PCC/PCu, LP rdlPFC (42, 47, 16) (38, 41, 22) 
MPF  = (-1, 47, -4) 
   PCC/Pcu =  (-5, -49, 40) 
   LP =  (-45, -67, 36) 
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Table 4 (continued) 
Article 
SN (bold)/CEN 
(italics) 
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
    
 
rINS (42, 10, -12) 
 
 
lINS (-40, 18, -12) 
 
 
rTP (52, 20, -18) 
 
 
lTP (-52, 16, -14) 
 
Seeley et al. (2007) CG (0,44, 28) 
 
Healthy Participants rdACC (6, 22, 30) 
 
Young Adult (ROI Analysis - Age: 18 -25) ldACC (-6, 18, 30) 
 
Young Adult / Adult / Elderly (ICA Analysis - Age: 18 - 70) rSMA/PreSMA (6, 8, 58) 
 
Resting State (eyes closed) lSMA/PreSMA (-4, 14, 48) 
 
ROIs derived from ICA with ICs spatially correlated to a-
priori constructed SN/CEN template 
rSTG (64, -38, 6) 
 
ICs which have the highest correlation to the ROIs in the 
template was selected as SN/CEN ROIs 
lSTG (-62, -16, 8) 
 
.  rPO (58, -40, 30) 
 
 
lPO (-60, -40, 40) 
 
 
lFP (-24, 56, 10) 
 
 
rvlPFC (42, 46, 0) 
 
 
rdlPFC (30, 48, 22) 
 
 
ldlPFC (-38, 52, 10) 
 
 
lINS (-36, 24, -10) 
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rdlPFC (46, 46, 14) 
 
 
ldlPFC (-34, 46, 6) 
 
 
rvlPFC (34, 56, -6) 
 
 
lvlPFC (-32, 54, -4) 
 
 
FO (56, 14, 14) 
 
 
rdlPFC/FEF (30, 12, 60) 
 
 
ldlPFC/FEF (-32, 18, 50) 
 
 
dMPFC (0, 36, 46) 
 
 
rLPC (38, -56, 44) 
 
 
lLPC (-48, -48, 48) 
 
 
IT (58, -54, -16) 
 
        
Article 
SN (bold)/CEN 
(italics)  
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
    Zhou et al. (2007) ldlPFC (-48, 39, 12) 
 
Healthy Participants / Schizophrenia Patients rdlPFC (48, 42, 21) 
 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) rINS (36, 21, 3) 
 
Resting State (eyes closed) lINS (-33, 21, 3) 
 
ROIs derived from FC of seed region, so any regions that 
was active at the same time as the seed region was chosen as 
SN ROIs 
rIPL/PostCG (63, -30, 33) 
 
Seed for SN/CEN - rDPLFC lIPL/PostCG (-51, -36, 45)   
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Sridharan et al. (2008) rFIC (37, 25, -4) 
 
Healthy lFIC (-32, 24, -6) 
 
Young Adult / Adult (19 - 29) ACC (4, 30, 30) 
 
Resting State (eyes closed) rdlPLFC (45, 16, 45) 
 
Auditory Task (listening to Baroque music) rPPC (54, -50, 50) 
 
Visual Oddball Task lPPC (-38, -53, 45) 
 
ROI derived from ICA of Auditory Task only       
 
Article 
SN (bold)/CEN 
(italics) 
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    
 
lINS (-43, -10, 7)    (-41, -11, 9) 
 
rINS (46, 2, -6)   (42, 0, 0) 
White et al. (2010)  lSTG (-53, -30, 16)  (-50, -31, 15) 
Healthy Participants / Schizophrenia Patients rSTG (59, -28, 8) (53, -29, 10) 
Young Adult / Adult (20 - 37) lPcG (-66, 5, 5)  (-62, 3, 8) 
Visual Stimuli (eyes fixated on crosshair) rPcG (61, 4, 10) (55, 1, 14) 
Somatosensory Stimuli (vibratory stimuli to right index fingertip) lACG (-5, 35, 28)      (-6, 22, 40) 
ROI derived from ICA rACG (5, 29, 37)  (3, 28, 32) 
ROI determined with visual inspection based on their spatial 
distribution from previous studies 
rMeFG (5, 15, 47)  (3, 8, 47) 
 
lSFG (-31, 58, 15)   (-30, 51, 22) 
 
rSFG (34, 20, 10) (30, 16, 15)             
 
lMFG (-50, 24, 40) (-48, 17, 41) 
 
rMFG (53, 27, 40) (48, 20, 43) 
 
lIPL (-57, -45, 51) (-54, -48, 45) 
 
rIPL (62, -35, 49)  (56, -39, 46) 
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rAG (50,-65, 41) (45, -70, 35) 
        
 
   
    
Article SN/CEN  
MNI 
Coordinates  
Original Talairach 
coordinates if 
present 
    Liu et al. (2012) ACC (-1, 29, 18) (-2, 24, 23) 
Healthy Participants CG (-1, 31, 24) (-2, 25, 28) 
Alzheimer's Disease (AD) AI (-44, 15, -8) (-42, 13, -2) 
Healthy Control - (49 - 78) MFG (-29, 59, 14) (-28, 52, 21) 
AD patients - (43 - 76) STG (-51, 17, -13) (-48, 15, -7) 
Resting State (eyes closed) ACC (5, 37, -20 (4, 34, -10) 
ROI derived from ICA with ICs spatially correlated to a template Caudate (-6, 15, -13) (-6, 13, -6) 
ICs which have the highest correlation to template was selected as 
DMN 
IFG (-23, 24, -23) (-22, 23, -15) 
Template based on previous studies MFG (-23, 26, -24) (-22, 25, -15) 
 
MeFG (3, 59, -14) (2, 54, -3) 
 
SFG (9, 61, -12) (8, 56, -1) 
 
   
 
 
 
 
 
 
 
 
 
 
   
 
48 | P a g e  
 
 
 
 
Article 
SN (bold)/CEN 
(italics) 
MNI 
Coordinates  
Original 
Talairach 
coordinates if 
present 
    
 
lIPL (-45, -66, 39) 
 
 
rIPL (54, -45, 45) 
 
Fornito et al. (2012) lIFG (-48, 18, 24) 
 
Healthy  rIFG (54, 21, 15) 
 
Adults (19 - 36) ldMPFC (-6, 36, 42) 
 
Memory Task (MT) lFO (-36, 18, -18) 
 
ROI derived from ICA with ICs spatially correlated to a template lMTG (-60, -45, -6) 
 
ICs which have the highest correlation to template was selected 
as SN/CEN ROIs 
rMTG (-36, -6, 21) 
 ROI determined with visual inspection based on their 
anatomical distribution and comparisons from prior literature  
rMFG (21, 57, 24) 
 
 
rAI (39, 24, -6) 
 
 
lSPL (-39, -51, 48) 
        
 
  
 
 
laPFC (-36, 57, 9) 
 
Gao & Lin (2012)  raPFC (34, 52, 10) 
 
Healthy Participants ACC (3, 31, 27) 
 
Adult (25 - 33) laIPL (-52, -49, 47) 
 
Resting State (eyes closed) raIPL (52, -46, 46) 
 
Finger Tapping Task ldIPFC (-50, 20, 34) 
 
Movie Watching rdlPFC (46, 14, 43) 
 
Pre-selected ROI from Vincent et al. 2008 (labelled as FPCN) lINS (-31, 21, -1) 
 
 
rINS (31, 22, -2) 
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Table 5 
List of ROI Abbreviations 
 
Abbreviations Regions 
    
l left 
r right 
AC Anterior Cingulate  
ACC Anterior Cingulate Cortex 
ACG Anterior Cingulate Gyrus 
AG Angular Gyrus 
AI Anterior Insula 
aINS anterior Insula 
aIPL anterior Inferior Parietal Lobule 
aIPS anterior Intraparietal Suclus 
aMPFC anterior Medial Prefrontal Cortex 
aPFC anterior Prefrontal Cortex 
CB Caudate Body 
CG Cingulate Gyrus 
CH Caudate Head 
CPL Cerebellar Posterior Lobe 
CT Cerebellar Tonsils 
dACC dorsal Anterior Cingulate Cortex 
dlPFC dorsolateral Prefrontal Cortex 
dMPFC dorsomedial Prefrontal Cortex 
dPreCS dorsal Precentral Sulcus 
FEF Frontal Eye Fields 
FIC Fronto-Insular Cortex 
FG Fusiform Gyrus 
FO Frontal Operculum 
FP Frontal Pole 
HC Hippocampus 
HF  Hippocampal Formation 
IFG Inferior Frontal Gyrus 
INS Insula 
IOG Inferior Occipital Gyrus 
IPC Inferior Parietal Cortex 
IPL Inferior Parietal Lobule 
IPS Intraparietal Sulcus 
IT Inferior Temporal 
ITC Inferior Temporal Cortex 
InferoTC Inferolateral Temporal Cortex 
ITG Inferior Temporal Gyrus 
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LP Lateral Parietal Region 
LPC Lateral Parietal Cortex 
LPFC Lateral Prefrontal Cortex 
LTC Lateral Temporal Cortex 
MCC Middle Cingulate Cortex 
MeFG Medial Frontal Gyrus 
MeTG Medial Temporal Gyrus 
MesTL Mesial Temporal Lobe 
MiCG Mid Cingulate Gyrus 
MFG Middle Frontal Gyrus 
MOG Middle Occipital Gyrus 
MPFC Medial Prefrontal Cortex 
MPFG Medial PreFrontal Gyrus 
MTC Medial Temporal Cortex 
MTG Middle Temporal Gyrus 
MT+ Middle Temporal Area 
OFC Orbital Frontal Cortex 
OFG Orbital Frontal Gyrus 
PC Posterior Cingulate 
PCC Posterior Cingulate Cortex 
PcG Precentral Gyrus 
PCG Posterior Cingulate Gyrus 
PCeS Precentral Sulcus 
PCu Precuneus 
PHG Parahippocampal Gyrus 
pIPL  posterior Inferior Parietal Lobule 
pIPS posterior Intraparietal Sulcus 
PL Parietal Lobule 
PO Parietal Operculum 
PPC Posterior Parietal Cortex 
PreCG Precentral Gyrus 
pSTS posterior Superior Temporal Sulcus 
rAG Angular Gyrus 
RO Rolandic Operculum 
Rsp Restrosplenial 
SFC Superior Frontal Cortex 
SFG Superior Frontal Gyrus 
SMA Supplementary Motor Area 
SOG Superior Occipital Gyrus 
SPL Superior Parietal Lobule 
STG Superior Temporal Gyrus 
STS Superior Frontal Sulcus 
TG Temporal Gyrus 
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TP Temporal Pole 
TPJ Temporo-Parietal Junction 
vACC ventral Anterior Cingulate Cortex 
vlPFC ventrolateral Prefrontal Cortex 
vIPS ventral Intraparietal Sulcus 
vMPFC Ventral Medial Prefrontal Cortex 
VP Ventral Precuneus 
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2.8 Definition of DMN ROIs 
 
      The DMN included the posterior cingulate cortex (PCC), dorsal medial prefrontal 
cortex (dMPFC), ventral medial prefrontal cortex (vMPFC), left posterior inferior parietal 
lobule (lpIPL), right posterior inferior parietal lobule (rpIPL), left middle temporal region 
(lMTG), and right middle temporal region (rMTG). The location of these ROIs in the brain is 
presented from Figure 1 to Figure 5.  
The PCC, dMPFC, and vMPFC, were divided into the left and right region, by 
deleting the single midline brain voxels and then adjusting the ROIs to minimise the inclusion 
of cerebrospinal fluid (CSF) or white matter tracts. These modifications to the ROI were done 
in standard space with Magnetic Resonance Image conversion v4 (MRIcron version 4, April 
2011; Rorden & Brett, 2000, http://www.mccauslandcenter.sc.edu/mricro/mricron/), a 
standalone program that allows efficient viewing and exporting of brain images, as well as 
aiding in the drawing and editing of anatomical ROIs, after the ROIs were constructed (refer 
to ROI Analysis below).  The newly modified left and right PCC, dMPFC, and vMPFC in the 
brain are presented from Figure 1 to Figure 3.  
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Figure 1 
PCC in the DMN (location derived from mean coordinate analysis in current study) 
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Figure 2 
dMPFC in the DMN (location derived from mean coordinate analysis in current study) 
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Figure 3 
vMPFC in the DMN (location derived from mean coordinate analysis in current study) 
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Figure 4 
pIPL in the DMN (6mm sphere, location derived from mean coordinate analysis in current 
study) 
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Figure 5 
MTG in the DMN (location derived from mean coordinate analysis in current study) 
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2.9 Definition of DAN ROIs 
 
      The left frontal eye fields (lFEF), right frontal eye fields (rFEF), left posterior intra 
parietal sulcus (lpIPS), right posterior intra parietal sulcus (rpIPS), left anterior intra parietal 
sulcus (laIPS), right anterior intra parietal sulcus (raIPS), left middle temporal area (lMT+), 
and right middle temporal area (rMT+) are the ROIs that were selected as part of the DAN. 
The location of these ROIs in the brain is presented from Figure 6 to Figure 9.  
2.10 Definition of SN/CEN ROIs 
 
      The SN ROIs comprised of the left anterior cingulate cortex (lACC), right anterior 
cingulate cortex (rACC), left insula (lINS), and the right insula (rINS). The location of these 
ROIs in the brain is presented in Figure 10 and Figure 11. 
The CEN ROIs included the left dorsal lateral prefrontal cortex (ldlPFC), right dorsal 
lateral prefrontal cortex (rdlPFC), left anterior inferior parietal lobule (laIPL), and right 
anterior inferior parietal lobule (raIPL). The location of these ROIs in the brain is presented 
in Figure 12 and Figure 13. 
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Figure 6 
FEF in the DAN (location derived from mean coordinate analysis in current study) 
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Figure 7 
pIPS in the DAN (location derived from mean coordinate analysis in current study) 
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Figure 8 
aIPS in the DAN (location derived from mean coordinate analysis in current study) 
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Figure 9 
MT+ in the DAN (location derived from mean coordinate analysis in current study) 
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Figure 10 
ACC in the SN (location derived from mean coordinate analysis in current study) 
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Figure 11 
INS in the SN (location derived from mean coordinate analysis in current study) 
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Figure 12 
dlPFC in the CEN (location derived from mean coordinate analysis in current study) 
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Figure 13 
aIPL in the CEN (location derived from mean coordinate analysis in current study) 
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2.11 Formation of Mean ROI Coordinate  
 
      The ROIs and their corresponding (x, y, z) coordinates were then organized based on 
their label (e.g. the dMPFC and its coordinates from different studies were considered 
together). The total number of coordinates for a particular ROI averaged across the selected 
studies, generated the mean coordinate that were used to define the location of the ROI in a 
particular network: 
∑    
 
           
 
 
where n is the number of studies that contain the particular ROI and its corresponding 
coordinate, xi is the x coordinate from study i, yi is the y coordinate from study i, and zi is the 
z coordinate from study i.  
The complete list of ROIs, their corresponding coordinates, the particular cognitive 
network a ROI belongs to, and the health status, age and number of participants from selected 
studies for each ROI is summarised in the following tables: Table 6 to Table 12 show the 
studies assessed to derive the mean coordinates for the ROIs in DMN, Table 13 to Table 20 
for DAN, Table 21 to Table 24 for SN, and Table 25 to Table 28 for CEN. Table 29 presents 
the final derived mean MNI coordinate for each ROI in each network. Figure 1 to Figure 13 
(see above) show the location of these ROIs in the brain, based on the coordinates provided 
in Table 29. 
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Table 6 
         
Studies assessed for the formation of the mean coordinate for PCC in the DMN 
Studies PCC Coordinate 
    
Fox et al. (2005) (-1, -34, 40)    
Healthy 
 
(N = 10)   
  
Zhou et al. (2007) 
 
Healthy / Schizophrenia (6 , -54, 30) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
  
Harrison et al. (2008) 
 
Healthy  (-3, -57, 30) 
Young Adult (Mean Age ± SD: 26 ± 3.5) 
 
(N =22)   
  
Mohammadi et al. (2009) 
 
Healthy / Amyotrophic Lateral Sclerosis (-4, -53, 24) 
Middle Age / Elderly (45 - 68) 
 
(N = 20)   
  
Boly et al. (2009) 
 
Healthy / Vegetative State / Brain Dead (2, -56, 30) 
Middle Age (Mean Age ± SD: 41 ± 11) 
 
(N = 6) 
 
 
  
Meindl et al. (2010) 
 
Healthy  (-1, -54, 27) 
Young Adult / Adult (23 - 36) 
 
(N = 18)   
  
Wu et al. (2011) 
 
Healthy (3, -53, 16) 
Middle Age / Elderly (53 - 79) 
 
(N = 15)   
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Liao et al. (2011) 
 
Healthy / Mesial Temporal Lobe Epilepsy (-6, -54, 36) 
Young Adult / Middle Age (18 -51) 
 
(N = 20)   
  
Allen et al. (2011) 
 
Healthy (0, -52, 22) 
Age Varies (Mean Age ± SD: 23.4 ± 9.2) 
 
(N = 603)   
 
  
Camchong et al. (2011) 
 
Healthy / Schizophrenia (1, -57, 31) 
Middle Age (Mean Age = 41) 
 
(N = 58)   
  
Song et al. (2011) 
 
Healthy / Generalized Tonic-Clonic Seizures (-3, -45, 33) 
Control - (Mean Age ± SD: 27.1 ± 4.5) 
 
GTCS Patients - (Mean Age ± SD: 26.1 ± 6.1) 
 
(N = 43)   
  
Li et al. (2011) 
 
Healthy  (6, -49, 25) 
Young Adult (Mean Age ± SD: 21 ± 3.4) 
 
(N = 12)   
  
Tomasi & Volkow (2011) 
 
Healthy (6, -51, 33)       
Young Adult /  Adult / Elderly 
 
(N = 969)   
  
Koch et al. (2012) 
 
Healthy / Mild Cognitive Impairment / Alzheimer's 
disease 
(0, -53, 25) 
Elderly (57 - 100) 
 
(N = 53)   
  
Gao & Lin (2012) 
 
Healthy (1, -55, 17) 
Adult (25 - 33) 
 
(N = 19)   
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Qi et al. (2012) 
 
Healthy / minimal Hepatic Encephalopathy (0, -43, 40) 
Control - (Mean Age ± SD: 55 ± 9.5) 
 
mHE Patients - (Mean Age ± SD: 56.6 ± 9.1) 
 
(N = 19)   
  
Liu et al. (2012) 
 
Healthy / Alzheimer’s Disease 
 
Control - (49 - 78) (0, -50, 44)                                      
AD patients - (43 - 76) 
 
(N = 36)   
  
Jin et al. (2012) 
 
Healthy / amnesic Mild Cognitive Impairment 
 
Elderly (Healthy - Mean Age ± SD: 60.63 ± 8.3) (-6, -60, 22) 
Elderly (aMCI - Mean Age ± SD: 60.88 ± 3.22) 
 
(N = 18)   
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Table 7 
Studies assessed for the formation of the mean coordinate for dMPFC in the DMN 
Studies dMPFC Coordinates 
    
Fox et al. (2005) 
 
Healthy (0, 51, 2)    
(N = 10)   
  Zhou et al. (2007) 
 
Healthy / Schizophrenia (0, 53, 14) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
 
 
Harrison et al. (2008) 
 
Healthy  (-9, 57, 24)                                     
 (Mean Age ± SD: 26 ± 3.5) 
 
(N =22)   
  Mohammadi et al. (2009) 
 
Healthy / Amyotrophic Lateral Sclerosis (-2, 41, 29)           
Middle Age / Elderly (45 - 68) 
 
(N = 20)   
 
 
Bluhm et al. (2009) 
 
Healthy / Depression (-2, 68, 12) 
Young Adults / Adults (17 - 35) 
 (N = 15)   
 
 
Meindl et al. (2010) 
 Healthy  (0, 54, 7) 
Young Adult / Adult (23 - 36) 
 (N = 18)   
  Tomasi & Volkow (2011) 
 Healthy (0, 57, 16) 
Young Adult /  Adult / Elderly 
 (N = 969)   
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Wu et al. (2011) 
 
Healthy / Alzheimer's Disease (3, 46, 16) 
Middle Age / Elderly (53 - 79) 
 
(N = 15)   
 
 
Song et al. (2011) 
 
Healthy / Epilepsy (-3, 57, 21) 
Control - (Mean Age ± SD: 27.1 ± 4.5) 
 
Epilepsy Patients - (Mean Age ± SD: 26.1 ± 6.1) 
 (N = 43)   
  
Li et al. (2011) 
 
Healthy  (-12, 62, 8) 
Young Adult (Mean Age ± SD: 21 ± 3.4) 
 
(N = 12)   
  
Yeo et al. (2011) 
 Healthy (-7, 49, 18) 
Young Adult / Adult (18 - 35) 
 (N = 1000)   
  Tomasi & Volkow (2011) 
 
Healthy (0, 57, 16)      
Young Adult /  Adult / Elderly 
 (N = 969)   
  Jin et al. (2012) 
 Healthy / amnesic Mild Cognitive Impairment 
 
Elderly (Healthy - Mean Age ± SD: 60.63 ± 8.3) (8, 46, 36) 
Elderly (aMCI - Mean Age ± SD: 60.88 ± 3.22) 
 (N = 18)   
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Table 8 
Studies assessed for the formation of the mean coordinate for vMPFC in the DMN 
Studies vMPFC Coordinates 
    
Scheeringa et al. (2008) 
 
Healthy (-6, 20, -14) 
Young Adult (18 -28) 
 (N = 20)   
 
 
Boly et al. (2009) 
 
Healthy / Vegetative State / Brain Dead (2, 62, -2) 
Middle Age (Mean Age ± SD: 41 ± 11) 
 (N = 6)   
  Liao et al. (2011) 
 
Healthy / Mesial Temporal Lobe Epilepsy (0, 54, -6) 
Young Adult / Middle Age (18 -51) 
 
(N = 20)   
  Allen et al. (2011) 
 
Healthy (-1, 45, -9) 
Age Varies (Mean Age ± SD: 23.4 ± 9.2) 
 
(N = 603)   
 
 
Camchong et al. (2011) 
 
Healthy / Schizophrenia (-2, 56, -2) 
Middle Age (Mean Age = 41) 
 
(N = 58)   
  Gao & Lin (2012) 
 
Healthy (0, 51, -7) 
Adult (25 - 33) 
 
(N = 19)   
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Table 9 
Studies assessed for the formation of the mean coordinate for left pIPL in the DMN 
Studies lpIPL Coordinates 
  Fox et al. (2005) 
 
Healthy (-49, -67, 49)        
(N = 10)   
 
 
Zhou et al. (2007) 
 
Healthy / Schizophrenia (-42, -69, 33) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
 
 
Harrison et al. (2008) 
 
Healthy  (-48, -57, 24)                
 (Mean Age ± SD: 26 ± 3.5) 
 
(N =22)   
  Scheeringa et al. (2008) 
 
Healthy (-42, -68, 28) 
Young Adult (18 -28) 
 (N = 20)   
 
 
Mohammadi et al. (2009) 
 
Healthy / Amyotrophic Lateral Sclerosis (-46, -60, 31)                        
Middle Age / Elderly (45 - 68) 
 (N = 20)   
 
 
Bluhm et al. (2009) 
 
Healthy / Depression (-50, -60, 30) 
Young Adults / Adults (17 - 35) 
 
(N = 15)   
  Boly et al. (2009) 
 
Healthy / Vegetative State / Brain Dead (-48, -66, 48) 
Middle Age (Mean Age ± SD: 41 ± 11) 
 (N = 6)   
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Schöpf et al. (2010) 
 
Healthy (-48, -60, 36) 
Age varies (Mean Age ± SD: 27.3 ± 7.1) 
 (N = 28)   
 
 
Meindl et al. (2010) 
 
Healthy  (-42, -67, 31) 
Young Adult / Adult (23 - 36) 
 
(N = 18)   
  Wu et al. (2011) 
 
Healthy / Alzheimer's Disease (-49, -60, 31)      
Middle Age / Elderly (53 - 79) 
 
(N = 15)   
  Liao et al. (2011) 
 
Healthy / Mesial Temporal Lobe Epilepsy (-42, -66, 33) 
Young Adult / Middle Age (18 -51) 
 
(N = 20)   
  Allen et al. (2011) 
 
Healthy (-43, -69, 33) 
Age Varies (Mean Age ± SD: 23.4 ± 9.2) 
 (N = 603)   
 
 
Camchong et al. (2011) 
 
Healthy / Schizophrenia (-34, -62, 36) 
Middle Age (Mean Age = 41) 
 
(N = 58) 
 
 
  
Song et al. (2011) 
 
Healthy / Epilepsy (-54, -69, 36) 
Control - (Mean Age ± SD: 27.1 ± 4.5) 
 
Epilepsy Patients - (Mean Age ± SD: 26.1 ± 6.1) 
 
(N = 43)   
  
Li et al. (2011) 
 
Healthy  (-43, -67, 33) 
Young Adult (Mean Age ± SD: 21 ± 3.4) 
 (N = 12)   
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Yeo et al. (2011) 
 
Healthy (-41, -60, 29) 
Young Adult / Adult (18 - 35) 
 (N = 1000)   
 
 
Tomasi & Volkow (2011) 
 
Healthy (-51, -63, 31)       
Young Adult /  Adult / Elderly 
 
(N = 969)   
 
 
Koch et al. (2012) 
 
Healthy / Mild Cognitive Impairment / Alzheimer's 
disease 
(-44, -67, 24)                                  
Elderly (57 - 100) 
 
(N = 53)   
 
 Gao & Lin (2012) 
 Healthy 
 
Adult (25 - 33) (-47, -71, 29) 
(N = 19)   
 
 
Qi et al. (2012) 
 Healthy / minimal Hepatic Encephalopathy 
 
Control - (Mean Age ± SD: 55 ± 9.5) (-33, -76, 40) 
mHE Patients - (Mean Age ± SD: 56.6 ± 9.1) 
 (N = 19)   
  Liu et al. (2012) 
 
Healthy / Alzheimer’s Disease (-50, -61, 45)               
Control - (49 - 78) 
 AD patients - (43 - 76) 
 (N = 36)   
  De Vogelaere et al. (2012) 
 
Healthy / Mild Cognitive Impairment (-51, -69, 24) 
Adults (19 - 36) 
 (N = 32)   
 
 
 Jin et al. (2012) 
 Healthy / amnesic Mild Cognitive Impairment 
 
Elderly (Healthy - Mean Age ± SD: 60.63 ± 8.3) (-46, -42, 54) 
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Elderly (aMCI - Mean Age ± SD: 60.88 ± 3.22) 
 (N = 18)   
Table 10 
Studies assessed for the formation of the mean coordinate for rpIPL in the DMN 
 
Studies rpIPL Coordinates 
    
Zhou et al. (2007) 
 
Healthy / Schizophrenia (48, -57, 30) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
 
 
Scheeringa et al. (2008) 
 
Healthy (46, -64, 36) 
Young Adult (18 -28) 
 (N = 20)   
 
 
Mohammadi et al. (2009) 
 
Healthy / Amyotrophic lateral sclerosis (50, -57, 28)               
Middle Age / Elderly (45 - 68) 
 (N = 20)   
 
 
Boly et al. (2009) 
 
Healthy / Vegetative State / Brain Dead (62, -58, 28) 
Middle Age (Mean Age ± SD: 41 ± 11) 
 (N = 6)   
  Schöpf et al. (2010) 
 
Healthy (50, -70, 34) 
Age varies (Mean Age ± SD: 27.3 ± 7.1) 
 (N = 28)   
 
 
Meindl et al. (2010) 
 
Healthy  (48, -60, 29) 
Young Adult / Adult (23 - 36) 
 
(N = 18)   
  Wu et al. (2011) 
 
Healthy / Alzheimer's Disease (54, -60, 28)     
Middle Age / Elderly (53 - 79) 
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(N = 15)   
 
 
 
 
 Liao et al. (2011) 
 
Healthy / Mesial Temporal Lobe Epilepsy (54, - 63, 36)  
Young Adult / Middle Age (18 -51) 
 
(N = 20)   
  Allen et al. (2011) 
 
Healthy (47, -66, 32) 
Age Varies (Mean Age ± SD: 23.4 ± 9.2) 
 (N = 603)   
 
 
Camchong et al. (2011) 
 
Healthy / Schizophrenia (42, -54, 36) 
Middle Age (Mean Age = 41) 
 
(N = 58) 
 
 
  
Song et al. (2011) 
 
Healthy / Epilepsy (54, -63, 33) 
Control - (Mean Age ± SD: 27.1 ± 4.5) 
 
Epilepsy Patients - (Mean Age ± SD: 26.1 ± 6.1) 
 
(N = 43)   
  
Li et al. (2011) 
 
Healthy  (45, -60, 29) 
Young Adult (Mean Age ± SD: 21 ± 3.4) 
 (N = 12)   
  
Tomasi & Volkow (2011) 
 
Healthy (51, -61, 30)       
Young Adult /  Adult / Elderly 
 (N = 969)   
  Koch et al. (2012) 
 
Healthy / Mild Cognitive Impairment / Alzheimer's 
disease 
(50, -62, 19)                
Elderly (57 - 100) 
 
(N = 53)   
 
 Gao & Lin (2012) 
 Healthy 
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Adult (25 - 33) (50, -64, 27)  
(N = 19)   
 
 
 
 
Qi et al. (2012) 
 Healthy / minimal Hepatic Encephalopathy 
 
Control - (Mean Age ± SD: 55 ± 9.5) (51, -70, 43) 
mHE Patients - (Mean Age ± SD: 56.6 ± 9.1) 
 (N = 19)   
  De Vogelaere et al. (2012) 
 
Healthy / Mild Cognitive Impairment (51, -66, 24) 
Adults (19 - 36) 
 (N = 32)   
  Jin et al. (2012) 
 Healthy / amnesic Mild Cognitive Impairment 
 
Elderly (Healthy - Mean Age ± SD: 60.63 ± 8.3) (48, -72, 30) 
Elderly (aMCI - Mean Age ± SD: 60.88 ± 3.22) 
 (N = 18)   
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Table 11 
Studies assessed for the formation of the mean coordinate for left MTG in the DMN 
Studies lMTG Coordinates 
    
Zhou et al. (2007) 
 
Healthy / Schizophrenia (-60, -6, -24) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
 
 
Harrison et al. (2008) 
 
Healthy  (-57, -9, -24)             
Young Adult (Mean Age ± SD: 26 ± 3.5) 
 
(N =22)   
 
 
Scheeringa et al. (2008) 
 
Healthy (-62, -2, -24) 
Young Adult (18 -28) 
 (N = 20)   
  Mohammadi et al. (2009) 
 
Healthy / Amyotrophic lateral sclerosis (-53, 1, -17)    
Middle Age / Elderly (45 - 68) 
 (N = 20)   
  Schöpf et al. (2010) 
 
Healthy (-60, -14, -22) 
Age varies (Mean Age ± SD: 27.3 ± 7.1) 
 (N = 28)   
  Wu et al. (2011) 
 
Healthy / Alzheimer's Disease (-60, -12, -16)      
Middle Age / Elderly (53 - 79) 
 
(N = 15)   
 
 
Liao et al. (2011) 
 
Healthy / Mesial Temporal Lobe Epilepsy (-60, -12, -21) 
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Young Adult / Middle Age (18 -51) 
 
(N = 20) 
 
    
 
 
 
 Li et al. (2011) 
 
Healthy  (-59, -15, -16) 
Young Adult (Mean Age ± SD: 21 ± 3.4) 
 
(N = 12)   
  
Yeo et al. (2011) 
 
Healthy (-64, -20, -9) 
Young Adult / Adult (18 - 35) 
 (N = 1000)   
  Song et al. (2011) 
 
Healthy / Generalized Tonic-Clonic Seizures  (-54, -3, -30) 
Control - (Mean Age ± SD: 27.1 ± 4.5) 
 
GTCS Patients - (Mean Age ± SD: 26.1 ± 
6.1) 
 (N = 43)   
  Koch et al. (2012) 
 
AD / MCI / Healthy (-60, -12, -12)              
Elderly (57 - 100) 
 
(N = 53)   
  
De Vogelaere et al. (2012) 
 
Healthy / MCI (-63, -15, -15) 
Adults (19 - 36) 
 (N = 32)   
  Wang et al. (2012) 
 
Healthy / Generalized Tonic-Clonic Seizures  (-57, -3, -24) 
Adult (Healthy - Mean Age ± SD: 27.93 ± 
8.35) 
 Adult (GTCS - Mean Age ± SD: 27.37 ± 
4.50) 
 (N = 32)   
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Table 12 
Studies assessed for the formation of the mean coordinate for rMTG in the DMN 
Studies rMTG Coordinates 
    
Zhou et al. (2007) 
 
Healthy / Schizophrenia (63, -3, -24) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
 
 
Scheeringa et al. (2008) 
 
Healthy (64, -16, -18) 
Young Adult (18 -28) 
 (N = 20)   
  Mohammadi et al. (2009) 
 
Healthy / Amyotrophic lateral sclerosis (54, 2, -22)              
Middle Age / Elderly (45 - 68) 
 (N = 20)   
  Wu et al. (2011) 
 
Healthy / Alzheimer's Disease (63, -6, -19)        
Middle Age / Elderly (53 - 79) 
 
(N = 15)   
 
 
Liao et al. (2011) 
 
Healthy / Mesial Temporal Lobe Epilepsy (60, -3, -27) 
Young Adult / Middle Age (18 -51) 
 
(N = 20) 
 
 
  
  Song et al. (2011) 
 
Healthy / Generalized Tonic-Clonic Seizures  (54, 0, -30) 
Control - (Mean Age ± SD: 27.1 ± 4.5) 
 
GTCS Patients - (Mean Age ± SD: 26.1 ± 6.1) 
 (N = 43)   
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Table 13 
Studies assessed for the formation of the mean coordinate for left FEF in the DAN 
Studies lFEF Coordinates 
    
Fox et al. (2005) (-24, -7, 65)     
Healthy 
 (N = 10)   
  Fox et al. (2006) (-25, -7, 58 )   
Healthy 
 (N = 10)   
  Grady et al. (2010) 
 Healthy (-32, -8, 56) 
Young Adult / Elderly (20 - 30, 56 - 84) 
 (N = 47)   
  Gao & Lin (2012) 
 
Healthy (-25 -8, 50) 
Adult (25 - 33) 
 
(N = 19)   
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Table 14 
Studies assessed for the formation of the mean coordinate for right FEF in the DAN 
Studies rFEF Coordinates 
    
Fox et al. (2005) (32, -1, 56)       
Healthy 
 
(N = 10)   
 
  
Fox et al. (2006) (32, -5, 55)                          
Healthy 
 
(N = 10)   
  
Grady et al. (2010) 
 
Healthy (28, -4, 48) 
Young Adult / Elderly (20 - 30, 56 - 84) 
 
(N = 47)   
  
Gao & Lin (2012) 
 
Healthy (27, -8, 50) 
Adult (25 - 33) 
 
(N = 19)   
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Table 15 
Studies assessed for the formation of the mean coordinate for left pIPS in the DAN 
Studies 
lpIPS 
Coordinates 
    
Fox et al. (2005) 
 
Healthy (-23, -65, 53)      
(N = 10)   
  Fox et al. (2006) 
 
Healthy (-22, -67, 53)                            
(N = 10)   
  Grady et al. (2010) 
 
Healthy (-28, -60, 56) 
Young Adult / Elderly (20 - 30, 56 - 
84) 
 (N = 47)  
  Gao & Lin (2012) 
 
Healthy (-27, -52, 57)  
Adult (25 - 33) 
 
(N = 19)   
  Fornito et al. (2012) 
 
Healthy  (-27, -69, 39) 
Adults (19 - 36) 
 (N = 16)  
  Li et al. (2011) 
 
Healthy  (-39, -63, 56) 
Young Adult (Mean Age ± SD: 21 ± 
3.4)  
(N = 12)   
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Table 16 
Studies assessed for the formation of the mean coordinate for right pIPS in the DAN 
Studies rpIPS Coordinates 
    
Fox et al. (2005) 
 
Healthy (29, -56, 58)      
(N = 10)   
  Fox et al. (2006) 
 
Healthy (23, -65, 58)                        
(N = 10)   
  Grady et al. (2010) 
 
Healthy (28, -60, 48) 
Young Adult / Elderly (20 - 30, 56 - 84) 
 (N = 47)   
  Gao & Lin (2012) 
 
Healthy (24, -56, 55) 
Adult (25 - 33) 
 
(N = 19)   
  Li et al. (2011) 
 
Healthy  (42, -51, 52)   
Young Adult (Mean Age ± SD: 21 ± 3.4) 
 
(N = 12)   
  Liu et al. (2012) 
 
Healthy / Alzheimer's disease (43, -48, 62)                         
Control - (49 - 78) 
 
AD patients - (43 - 76) 
 
(N = 36)   
 
 
87 | P a g e  
 
 
 
 
 
 
Table 17 
Studies assessed for the formation of the mean coordinate for left aIPS in the DAN 
Studies laIPS Coordinates 
    
Fox et al. (2005) 
 
Healthy (-43, -41, 55)     
(N = 10)   
  Fox et al. (2006) 
 
Healthy (-43, -39, 46)                                 
(N = 10)   
  Grady et al. (2010) 
 
Healthy (-48, -40, 40) 
Young Adult / Elderly (20 - 30, 56 - 84) 
 (N = 47)   
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Table 18 
Studies assessed for the formation of the mean coordinate for right aIPS in the DAN 
  
Studies raIPS Coordinates 
    
Fox et al. (2005) rIPL 
Healthy (52, -33, 56)       
(N = 10)   
  Fox et al. (2006) raIPS 
Healthy (39, -45, 49)                       
(N = 10)   
  Grady et al. (2010) rIPL 
Healthy (44, -44, 44) 
Young Adult / Elderly (20 - 30, 56 - 84) 
 (N = 47)   
  Fornito et al. (2012) rIPS 
Healthy  (33, -45, 48)   
Adults (19 - 36) 
 (N = 16)   
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Table 19 
Studies assessed for the formation of the mean coordinate for left MT+ in the DAN 
Studies lMT+ Coordinates 
    
Fox et al. (2005) (-49, -72, -1)     
Healthy 
 (N = 10)   
  Fox et al. (2006) (-48, -72, -5)                     
Healthy 
 
(N = 10)   
  Zhou et al. (2007) 
 Healthy / Schizophrenia (-51, -57, -12) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 (N = 18)   
  Grady et al. (2010) 
 
Healthy (-48, -72, -4) 
Young Adult / Elderly (20 - 30, 56 - 84) 
 (N = 47)   
  Gao & Lin (2012) 
 
Healthy (-45, -69, -2) 
Adult (25 - 33) 
 
(N = 19)   
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Table 20 
Studies assessed for the formation of the mean coordinate for right MT+ in the DAN 
Studies rMT+ Coordinates 
    
Fox et al. (2005) (59, -69, -2)  
Healthy 
 (N = 10)   
  Fox et al. (2006) (56, -66, -7)                     
Healthy 
 
(N = 10)   
  Zhou et al. (2007) 
 Healthy / Schizophrenia (44, -64, -12) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 (N = 18)   
  Gao & Lin (2012) 
 
Healthy (50, -69, -3) 
Adult (25 - 33) 
 
(N = 19)   
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Table 21 
Studies assessed for the formation of the mean coordinate for left ACC in the SN 
Studies lACC Coordinates 
  Seeley et al. (2007) 
 
Healthy (-6, 18, 30) 
All Ages (18 - 70) 
 (N = 14)   
  White et al. (2010) 
 
Healthy / Schizophrenia (-5, 35, 28)       
Young Adult / Adult (20 - 37) 
 
(N = 19)   
  Liu et al. (2012) 
 
Healthy / Alzheimer Disease 
 
Control - (49 - 78) (-1, 29, 18)                       
AD patients - (43 - 76) 
 (N = 36)   
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Table 22 
Studies assessed for the formation of the mean coordinate for right ACC in the SN 
 
Studies rACC Coordinates 
  Seeley et al. (2007) 
 Healthy (6, 22, 30) 
All Ages (18 - 70) 
 (N = 14)   
  Sridharan et al. (2008) 
 
Healthy (4, 30, 30) 
Young Adult / Adult (19 - 29) 
 
(N = 13)   
  White et al. (2010) 
 
Healthy / Schizophrenia (5, 29, 37)        
Young Adult / Adult (20 - 37) 
 
(N = 19)   
  Gao & Lin (2012) 
 Healthy (3, 31, 27) 
Adult (25 - 33) 
 (N = 19)   
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Table 23 
Studies assessed for the formation of the mean coordinate for left INS in the SN 
Studies lINS Coordinates 
    
Fox et al. (2005) 
 
Healthy (-47, 7, 5)                             
(N = 10)   
  Seeley et al. (2007) 
 
Healthy (-40, 18, -12) 
All Ages (18 - 70) 
 (N = 14)   
  Zhou et al. (2007) 
 
Healthy / Schizophrenia (-33, 21, 3) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
  Sridharan et al. (2008) 
 
Healthy (-32, 24, -6) 
Young Adult / Adult (19 - 29) 
 (N = 13)   
  Gao & Lin (2012) 
 
Healthy (-31, 21, -1) 
Adult (25 - 33) 
 (N = 19)   
  Liu et al. (2012) 
 Healthy (AD data not included) 
 
Control - (49 - 78) (-44, 15, -8)                         
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AD patients - (43 - 76) 
 (N = 36)   
 
 
 
 
 
Table 24 
Studies assessed for the formation of the mean coordinate for right INS in the SN 
Studies rlINS Coordinates 
    
Fox et al. (2005) 
 
Healthy (49, 7, 10)                           
(N = 10)   
  Seeley et al. (2007) 
 
Healthy (42, 10, -12) 
All Ages (18 - 70) 
 (N = 14)   
  Zhou et al. (2007) 
 
Healthy / Schizophrenia (36, 21, 3) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
  Sridharan et al. (2008) 
 
Healthy (37, 25, -4) 
Young Adult / Adult (19 - 29) 
 (N = 13)   
  Gao & Lin (2012) 
 
Healthy (31, 22, -2) 
Adult (25 - 33) 
 (N = 19)   
  Fornito et al. (2012) 
 
Healthy  (39, 24, -6) 
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Adults (19 - 36) 
 (N = 16)   
 
 
 
 
 
 
Table 25 
Studies assessed for the formation of the mean coordinate for left dlPFC in the CEN 
 
Studies ldlPFC Coordinates 
  Fox et al. (2005) 
 
Healthy (-44, 45, 21)       
(N = 10)   
  Zhou et al. (2007) 
 
Healthy / Schizophrenia (-48, 39, 12) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
 
 
Table 26 
Studies assessed for the formation of the mean coordinate for right dlPFC in the CEN 
Studies rdlPFC Coordinates 
  Fox et al. (2005) 
 
Healthy (42, 47, 16)        
(N = 10) 
 
    
Zhou et al. (2007) 
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Healthy / Schizophrenia (48, 42, 21) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
 
 
 
 
 
 
Table 27 
Studies assessed for the formation of the mean coordinate for left laIPL in the CEN 
Studies laIPL Coordinates 
  Seeley et al. (2007) 
 
Healthy (-48, -48, 48) 
All Ages (18 - 70) 
 
(N = 14)   
 
 
Zhou et al. (2007) 
 
Healthy / Schizophrenia (-51, -36, 45) 
Young Adult (Mean Age ± SD: 24 ± 4.9 ) 
 
(N = 18)   
 
 
White et al. (2010) 
 
Healthy / Schizophrenia (-57, -45, 51)    
Young Adult / Adult (20 - 37) 
 
(N = 19)   
 
 
Gao & Lin (2012) 
 
Healthy (-52, -49, 47) 
Adult (25 - 33) 
 
(N = 19)   
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Table 28 
Studies assessed for the formation of the mean coordinate for right laIPL in the CEN 
Studies raIPL Coordinates 
    
Sridharan et al. (2008) 
 
Healthy (54, -50, 50) 
Young Adult / Adult (19 - 29) 
 
(N = 13)   
  Gao & Lin (2012) 
 
Healthy (52, -46, 46) 
Adult (25 - 33) 
 (N = 19)   
  Fornito et al. (2012) 
 
Healthy  (54, -45, 45) 
Adults (19 - 36) 
 (N = 16)   
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Table 29 
Mean coordinates of ROIs in all network derived from selected studies 
Network Regions of Interest Mean Coordinate 
DMN 
  
PCC (0, -51, 29) 
dMPFC (-2, 54, 17) 
vMPFC (-2, 48, -7) 
lpIPL (-45, -64, 34) 
rpIPL (50, -63, 31) 
lMTG (-59, -9, 20) 
rMTG (60, -7, -21) 
    
DAN 
  
lFEF (-26, -8, 57) 
rFEF (29, 0, 51) 
lpIPS (-28, -61, 53) 
rpIPS (30, -56, 55) 
laIPS (-45, -40, 47) 
raIPS (42, -42, 49) 
lMT+ (-46, -64, -1) 
rMT+ (52, -67, -5) 
    
SN 
  
lACC (-4, 27, 25) 
rACC (4, 28, 30) 
lINS (-37, 18, -3) 
rINS (38, 19, -2) 
    
CEN 
    
ldlPFC (-46, 42, 17) 
rdlPFC (45, 44, 19) 
laIPL (-52, -45, 48) 
raIPL (53, -47, 47) 
    
 
*refer to Table 5 for abbreviations 
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2.12 ROI Processing/Analysis 
 
     ROIs were first constructed in standard space (‘normalized/MNI space’). The ROIs 
were then warped into subject space for each individual. MarsBar 0.42, a toolbox for SPM5 
which allows for the construction and definition of ROIs, (MARSeille Boîte À Région 
d’Intérêt release 0.42; Brett, Anton, Valabregue, & Poline, 2002), was used to build the ROIs. 
The process was as follows: (1) MarsBar was accessed in SPM5, (2)‘Build’ was selected, (3) 
‘Type of ROI’ selected was sphere, (4) ‘Centre of sphere’ coordinates (x, y, z) for a particular 
ROI were entered based on meta-analysis findings, (5) A 6mm ‘sphere radius’ was selected, 
(6) ‘Description of ROI’ was used to label a particular ROI, (7) The ROI was saved as *.mat 
file, (8) The ROIs was then ‘exported’ as an image, and lastly, (9) The ROI (*.mat file) was 
converted to a NifTI (*.nii file) image.  
A radius of 6-mm was selected because this was estimated as an optimal size to cover 
all relevant voxels but exclude excessive white matter tracts or CSF in the brain. The .mat file 
format (MATLAB binary file format) was converted to .nii file format (NifTI data format) as 
MRIcron, the program that used to draw and edit anatomical ROIs in this study, cannot use 
the .mat file format. 
After all the ROIs for the cognitive networks were constructed in standard space, the 
next step of analysis involved applying inverse spatial normalization parameters to produce 
ROIs in the individual subject space of each participant. In other words, the ROIs in standard 
space were ‘customized’ to fit the brain of each participant. This process was conducted to 
reduce anatomical and functional variability, as the location of the subject space ROIs 
depends on the accuracy of the normalization, which may vary from individual to individual. 
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      To perform this ‘reverse engineering’ task, inverse normalization parameters were 
used to warp the ROIs in standard space into the subject space of each participant, by 
executing several MATLAB scripts (custom-made by Dr. Tracy Melzer to perform this task). 
Visual checks of the location for each ROI in the brain of every participant were then 
performed to examine whether ROIs appeared correctly placed or the ROIs covered excessive 
white matter tracts or CSF. In the event of any such problem, the ROIs were manually re-
adjusted using MRIcron.  
      After the visual checks and modifications were performed, the mean FA and MD 
value of each ROI in subject space for each participant were extracted. This analysis focused 
on DTI metrics within grey matter regions. Therefore, FA and MD values from only GM 
voxels contributed to the mean of a specific ROI. Co-registered GM and WM from the 
structural segmentation process were used to define voxels within each ROI as grey matter or 
white matter. To contribute to the mean FA/MD value for a given individual’s ROI, each 
voxel had to have a greater than 10% chance of being GM or WM (to eliminate contribution 
from CSF) and also have a FA value <0.3, indicative of GM (i.e. not pertaining to a white 
matter tract). If these conditions were met, the FA/MD value from that voxel was extracted 
and contributed to the calculation of the ROI’s mean FA/MD. 
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3. Results  
3.1 ANCOVA MD 
 
 ANCOVA (with age and education as covariates) followed by Newman-Keuls post-
hoc comparison tests were performed on the mean MD values for each participant group in a 
particular ROI for each RSN.  
The ANCOVA for the group main effects for MD in the left and right ROIs of the 
four networks are summarized on Table 30 and the mean values for the four participant 
groups for each ROI in every RSN are shown in Figure 14 to Figure 26. The Newman-Keuls 
Test tables are presented in the Appendix.  
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MD: Group main effect for the ANCOVA for each ROI for the four cognitive networks  
  dlPFC aIPL 
      
  Left Right Left Right 
      
CEN 
F (3,135) = 
3.07, p<.03 
F (3,135) = 
1.73, p=.2 
F (3,135) 
= .73, p=.5 
F (3,135) 
= .48, p=.7       
          
      
  ACC INS 
      
  Left Right Left Right 
      
SN 
F (3,135) = 
5.63, p<.001 
F (3,135) = 
6.68, p<.0003 
F (3,135) 
= 1.86, 
p=.1 
F (3,135) 
= 3.94, 
p<.01 
      
          
      
        FEF aIPS pIPS MT+ 
  
  Left Right Left Right Left Right Left Right 
  
DAN  
F (3,135) = 
.47, p=.7 
F (3,135) = 
3.33, p<.02 
F (3,135) 
= 4.15, 
p<.01 
F (3,135) 
= 2.06, 
p=.1 
F (3,135) 
= 2.64, 
p=.05 
F (3,135) 
= 1.25, 
p=.3 
F (3,135) 
= 6.03, 
p<.01 
F (3,135) 
= 3.17, 
p<.03 
  
                  
  
          PCC dMPFC vMPFC pIPL MTG 
  Left Right Left Right Left Right Left Right Left  Right 
DMN  
F (3,135) = 
4.34, p<.01 
F (3,135) = 
3.85, p<.01 
F (3,135) 
= 5.49, 
p<.001 
F (3,135) 
= 4.3, 
p<.01 
F (3,135) 
= 1.57, 
p=.2 
F (3,135) 
= 4.82, 
p<.003 
F (3,135) 
= 3.14, 
p<.03 
F (3,135) = 
.51, p=.7 
F (3,135) 
= 3.51, 
p<.02 
F (3,135) = 
3.89, 
p<.01 
                      
All bolded F-ratios are significant. Age and education of participants were used as co-variates; age was significant for all ROIs (p<0.05), except 
left ACC of the SN. Education was not significant for any ROI. For abbreviations, see Table 5. 
 
 
Table 30 
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Figure 14 
 
Differences between the means (±sem) of the MD of the PCC for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
0.00086
0.00088
0.00090
0.00092
0.00094
0.00096
0.00098
0.00100
0.00102
0.00104
M
D
 
Fig 14A. DMN ANCOVA showing lPCC: Pairwise group differences (N-K): (HC = PD-N) < (PD-
MCI = PD-D). 
HC PD-N PD-MCI PD-D
Group
0.00088
0.00090
0.00092
0.00094
0.00096
0.00098
0.00100
0.00102
0.00104
0.00106
0.00108
M
D
 
Fig 14B. DMN ANCOVA showing rPCC: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI) < PD-D. 
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Figure 15 
Differences between the means (±sem) of the MD of the dMPFC for the four groups 
controlling for age and education. 
HC PD-N PD-MCI PD-D
Group
0.0010
0.0011
0.0012
0.0013
0.0014
0.0015
M
D
 
Fig 15A. DMN ANCOVA showing ldMPFC: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI) < PD-D. 
HC PD-N PD-MCI PD-D
Group
0.00095
0.00100
0.00105
0.00110
0.00115
0.00120
0.00125
0.00130
0.00135
M
D
 
Fig 15B. DMN ANCOVA showing rdMPFC: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI) < PD-D. 
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Figure 16  
 
 Differences between the means (±sem) of the MD of the vMPFC for the four groups 
controlling for age and education. 
 
HC PD-N PD-MCI PD-D
Group
0.00095
0.00100
0.00105
0.00110
0.00115
0.00120
0.00125
0.00130
0.00135
M
D
 
Fig 16A. DMN ANCOVA showing lvMPFC: Pairwise group differences (N-K): (HC = PD-N) < PD-
D and PD-MCI not different to any other group. 
HC PD-N PD-MCI PD-D
Group
0.00088
0.00090
0.00092
0.00094
0.00096
0.00098
0.00100
0.00102
0.00104
0.00106
0.00108
0.00110
0.00112
M
D
 
Fig 16B. DMN ANCOVA showing rvMPFC: Pairwise group differences (N-K): (HC = PD-N) and 
PD-MCI) <  PD-D, HC < PD-MCI, and PD-N = PD-MCI. 
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Figure 17  
 
Differences between the means (±sem) of the MD of the pIPL for the four groups controlling 
for age and education. 
HC PD-N PD-MCI PD-D
Group
0.00094
0.00096
0.00098
0.00100
0.00102
0.00104
0.00106
0.00108
0.00110
0.00112
M
D
 
Fig 17A. DMN ANCOVA showing lpIPL: Pairwise group differences (N-K): HC = PD-N, HC < (PD-
MCI = PD-D), PD-N = PD-MCI, PD-N < PD-D. 
 
HC PD-N PD-MCI PD-D
Group
0.00093
0.00094
0.00095
0.00096
0.00097
0.00098
0.00099
0.00100
0.00101
0.00102
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0.00105
0.00106
M
D
 
Fig 17B. DMN ANCOVA showing rpIPL: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D).  
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Figure 18 
Differences between the means (±sem) of the MD of the MTG for the four groups controlling 
for age and education. 
HC PD-N PD-MCI PD-D
Group
0.00092
0.00094
0.00096
0.00098
0.00100
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0.00108
0.00110
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0.00116
M
D
 
 
Fig 18A. DMN ANCOVA showing lMTG: Pairwise group differences (N-K): (HC = PD-N) < (PD-
MCI = PD-D). 
HC PD-N PD-MCI PD-D
Group
0.00092
0.00094
0.00096
0.00098
0.00100
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0.00110
0.00112
M
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Fig 18B. DMN ANCOVA showing rMTG: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI) < PD-D. 
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Figure 19 
Differences between the means (±sem) of the MD of the FEF for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
0.00100
0.00102
0.00104
0.00106
0.00108
0.00110
0.00112
0.00114
M
D
 
Fig 19A. DAN ANCOVA showing lFEF: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D). 
HC PD-N PD-MCI PD-D
Group
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0.00114
0.00116
M
D
  
Fig 19B. DAN ANCOVA showing  rFEF: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI) < PD-D. 
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Figure 20 
Differences between the means (±sem) of the MD of the aIPS for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
0.00100
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0.00104
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0.00120
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Fig 20A. DAN ANCOVA showing laIPS: Pairwise group differences (N-K): HC = PD-N = PD-MCI, 
HC < PD-D, (PD-N = PD-MCI = PD-D). 
HC PD-N PD-MCI PD-D
Group
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M
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Fig 20B. DAN ANCOVA showing raIPS: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI) < PD-D. 
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Figure 21  
Differences between the means (±sem) of the MD of the pIPS for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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0.00108
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Fig 21A. DAN ANCOVA showing lpIPS: Pairwise group differences (N-K): HC = PD-N = PD-MCI, 
(HC = PD-N) < PD-D, PD-MCI = PD-D. 
HC PD-N PD-MCI PD-D
Group
0.00102
0.00104
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0.00110
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0.00120
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Fig 21B. DAN ANCOVA showing rpIPS: Pairwise group differences (N-K): HC = PD-MCI = PD-D, 
HC = PD-N, PD-N = PD-MCI, PD-N < PD-D. 
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Figure 22.  
Differences between the means (±sem) of the MD of the MT+ for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 22A. DAN ANCOVA showing lMT+: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI) < PD-D. 
 
HC PD-N PD-MCI PD-D
Group
0.00090
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0.00106
M
D
 
Fig 22B. DAN ANCOVA showing rMT+: Pairwise group differences (N-K): (HC = PD-N) < PD-D, 
HC = PD-MCI, PD-N <PD-MCI, PD-MCI = PD-D. 
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Figure 23  
Differences between the means (±sem) of the MD of the ACC for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 23A. SN ANCOVA showing lACC: Pairwise group differences (N-K): (HC = PD-N) < (PD-MCI 
= PD-D) 
HC PD-N PD-MCI PD-D
Group
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Fig 23B. SN ANCOVA showing rACC: Pairwise group differences (N-K): (HC = PD-N) < (PD-MCI 
= PD-D). 
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Figure 24  
 
Differences between the means (±sem) of the MD of the INS for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 24A. SN ANCOVA showing lINS: Pairwise group differences (N-K): (HC = PD-N) < PD-D, HC 
= PD-MCI, PD-N < (PD-MCI = PD-D) 
HC PD-N PD-MCI PD-D
Group
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0.00120
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Fig 24B. SN ANCOVA showing rINS: Pairwise group differences (N-K): (HC = PD-N) < PD-D, HC 
= PD-MCI, PD-N < PD-MCI < PD-D. 
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Figure 25  
 
Differences between the means (±sem) of the MD of the dlPFC for the four groups 
controlling for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 25A. CEN ANCOVA showing ldlPFC: Pairwise group differences (N-K): (HC = PD-N) < PD-D, 
HC = PD-N = PD-MCI, PD-MCI = PD-D. 
HC PD-N PD-MCI PD-D
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Fig 25B. CEN ANCOVA showing rdlPFC: Pairwise group differences (N-K): (HC = PD-N) < (PD-
MCI = PD-D). 
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Figure 26 
 
Differences between the means (±sem) of the MD of the aIPL for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
0.00098
0.00100
0.00102
0.00104
0.00106
0.00108
0.00110
0.00112
0.00114
0.00116
M
D
 
Fig 26A. CEN ANCOVA showing laIPL: Pairwise group differences (N-K): HC = PD-N = PD-MCI, 
HC < PD-D, PD-N = PD-MCI = PD-D. 
HC PD-N PD-MCI PD-D
Group
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Fig 26B. CEN showing ANCOVA raIPL: Pairwise group differences (N-K): HC = PD-N= PD-MCI = 
PD-D 
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As shown in Table 30, age have a significant effect on every ROI except the left ACC 
of the SN. Education has no effect on any ROI.   
      In the DMN, significant group main effects were found for both left and right PCC, 
dMPFC and the MTG, but only for the right vMPFC and left pIPL. Post-hoc Newman-Keuls 
(N-K) tests showed that the PD-D group had significantly higher MD values than the HC and 
PD-N groups for each ROI, except the right pIPL. The PD-D group also had significantly 
higher MD values than the PD-MCI group in most ROIs, except the left vMPFC, left MTG, 
and both left and right pIPL. The PD-MCI group had significantly higher MD values than the 
PD-N group in the left PCC and the left MTG, and higher than the HC in the same two 
regions plus also the right vMPFC and the left pIPL. There were no group differences for 
right IPL. No significant differences were found for any DMN ROI between the PD-N group 
and the HC group. To summarise, the PD-D group showed a decline in structural micro-
integrity relative to the PD-N and HC groups across all nodes of the DMN, except the right 
pIPL. The PD-MCI group showed a more selective change, for only a few nodes in the left 
hemisphere, specifically the left PCC, left vMPFC, left pIPL and left MTG, where they were 
similar to the PD-D group, although this leftward change was not significantly different to the 
PD-N and HC group for the left vMPFC and to the PD-N group only for the left pIPL. No 
differences were found between the PD-N and HC groups for all nodes. 
      For the DAN, significant group main effects were found for both left and right ROIs 
for the MT+, right FEF, and left laIPS. Post-hoc N-K tests show that the PD-D group had 
significantly higher MD values than both the HC and PD-N group for the left and right MT+, 
right FEF, right aIPS, and left pIPS, higher value than the HC group only for left aIPS, and 
higher value than the PD-N group only for right pIPS. The PD-D group also had significantly 
higher MD values than the PD-MCI group for the right FEF, right aIPS, and left MT+. The 
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PD-MCI group had significantly higher MD values than the PD-N group for the right MT+ 
only. There were no significant group differences in left FEF. No significant differences were 
found for any DAN ROI between the PD-MCI group and the HC group or between the PD-N 
group and HC group. In summary, the PD-D group displayed weaker structural micro-
integrity when compared to the PD-N or HC groups across all nodes of the DAN, except the 
left FEF. The PD-MCI group displayed a more selective change, which was sometimes 
intermediate between the PD-D group and other groups (left and right pIPS, left aIPS) with a 
suggestion of change to, right MT+, in particular. There were no deficits in the DAN for the 
PD-N group compared to the HC group. 
In the SN, significant group main effects were found for both left and right ROIs of 
the ACC and right INS. Post-hoc N-K tests show that the PD-D group had significantly 
higher MD values than the HC and PD-N group for both left and right ROIs of the ACC and 
INS. Interestingly, PD-D group and the PD-MCI were similar across three of the four SN 
nodes, with the PD-MCI group showing better integrity only for the right INS. The PD-MCI 
group had significantly higher MD values than the HC and PD-N group for both left and right 
rACC, and higher value than the PD-N group only for both left and right INS. No significant 
differences were found for between the PD-N group and HC group. To summarise, the PD-D 
group showed a decline in structural micro-integrity relative to the PD-N and HC groups 
across all nodes of the SN. The PD-MCI group was generally similar to the PD-D group for 
the DAN but the right INS showed relative integrity. No differences were found between the 
HC and PD-N groups for any SN nodes. 
 For the CEN, significant group main effects were only found for left dlPFC. Post-hoc 
N-K tests show that the PD-D group had significantly higher MD values than the HC and PD-
N group for both left and right dlPFC. The MD values across all nodes for the PD-D group 
did not significantly differ with the MD values of the nodes for the PD-MCI group. The PD-
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MCI group had significantly higher MD values than the HC and PD-N group for the right 
dlPFC only. There were no group differences in right aIPL. No significant differences were 
found between the HC and PD-N group. In summary, the PD-D group displayed weaker 
structural micro-integrity relative to the PD-N or HC groups for the dlPFC of the CEN, but 
relatively little change in the aIPL. The PD-MCI group showed an intermediate change for 
the dlPFC. Again, the PD-N and HC groups showed comparable MD values for the CEN. 
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3.2 ANCOVA FA 
 
ANCOVA (with age and education as covariates) followed by Newman-Keuls post-hoc 
comparison tests were performed on the mean FA values for each participant group for each 
ROI in a particular ROI for each RSN.  
The ANCOVA for the group main effects for FA in the left and right ROIs of the four 
networks are summarized on Table 31 and the mean values for the four participant groups for 
each ROI in every RSN are shown in Figure 27 to Figure 39. The Newman-Keuls Test tables 
are presented in the Appendix.  
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Table 31 
FA: Group main effect for the ANCOVA for each ROI for the four cognitive networks  
        
  dlPFC aIPL 
      
  Left Right Left Right 
      
CEN 
F (3,135) = 
1.84,  p = .1 
F (3,135) 
= 37, p=.8 
F (3,135) = 
2.13, p=.1 
F (3,135) = 
1.3, p=.3       
          
      
  ACC INS 
      
  Left Right Left Right 
      
SN 
F (3,135) = 
2.36, p=.1 
F (3,135) 
= 1.98, 
p=.1 
F (3,135) = 
4.34, p<.01 
F (3,135) = 
.87, p=.5       
          
      
        FEF aIPS pIPS MT+ 
  
  Left Right Left Right Left Right Left Right 
  
DAN  
F (3,135) = 
4.23, p <.01 
F (3,135) 
= .41, p=.8 
F (3,135) = 
2.05, p=.1 
F (3,135) = 
.89, p=.5 
F (3,135) = 
.67, p=.6 
F (3,135) = 
.93, p=.5 
F (3,135) 
= .62, 
p=.6 
F (3,135) = 
1.24, p=.3   
                  
  
          PCC dMPFC vMPFC pIPL MTG 
  Left Right Left Right Left Right Left Right Left  Right 
DMN  
F (3,135) = 
3.20, p <.03 
F (3,135) 
= 1.52, 
p=.2 
F (3,135) = 
.24, p=.9 
F (3,135) = 
1.16, p=.3 
F (3,135) = 
1.69, p=.2 
F (3,135) = 
1.73, p=.2 
F (3,135) 
= .85, 
p=.5 
F (3,135) = 
.1, p=.96 
F (3,135) 
= .2, p=.9 
F (3,135) = 
.13, p=.9 
                      
All bolded F-ratios are significant. Age and education of participants were used as co-variates; age was not significant for all ROIs (p<0.05), 
except right pIPL of the DMN; education was not significant for any ROI except right INS of the SN and left pIPS of the DAN. For 
abbreviations, see Table 5. 
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Figure 27 
Differences between the means (±sem) of the FA of the PCC for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
0.130
0.135
0.140
0.145
0.150
0.155
0.160
F
A
 
Fig 27A. DMN showing ANCOVA of lPCC: Pairwise group differences (N-K): HC = PD-N = PD-D, 
HC <PD-MCI, PD-N = PD-MCI = PD-D. 
HC PD-N PD-MCI PD-D
Group
0.130
0.132
0.134
0.136
0.138
0.140
0.142
0.144
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0.148
0.150
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F
A
 
Fig 27B. DMN showing ANCOVA of rPCC: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI = PD-D). 
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Figure 28  
 
Differences between the means (±sem) of the FA of the dMPFC for the four groups 
controlling for age and education. 
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Group
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Fig 28A. DMN showing ANCOVA of ldMPFC: Pairwise group differences (N-K): (HC = PD-N = 
PD-MCI = PD-D). 
HC PD-N PD-MCI PD-D
Group
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0.144
0.146
0.148
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F
A
 
Fig 28B. DMN ANCOVA showing rdMPFC: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI = PD-D). 
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Figure 29 
 
Differences between the means (±sem) of the FA of the vMPFC for the four groups 
controlling for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 29A. DMN ANCOVA showing lvMPFC: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI = PD-D). 
HC PD-N PD-MCI PD-D
Group
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Fig 29B. DMN ANCOVA showing rvMPFC: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI = PD-D). 
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Figure 30 
 
Differences between the means (±sem) of the FA of the pIPL for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 30A. DMN ANCOVA showing lpIPL: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D). 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 30B. DMN - rpIPL: Pairwise group differences (N-K): (HC = PD-N = PD-MCI = PD-D). 
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Figure 31  
 
Differences between the means (±sem) of the FA of the MTG for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 31A. DMN ANCOVA showing lMTG: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI = PD-D). 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 31B. DMN showing ANCOVA rMTG: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI = PD-D). 
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Figure 32  
 
Differences between the means (+sem) of the FA of the FEF for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 32A. DAN showing ANCOVA lFEF: Pairwise group differences (N-K): (HC = PD-N = PD-MCI) 
< PD-D. 
HC PD-N PD-MCI PD-D
Group
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0.156
F
A
 
Fig 32B. DAN ANCOVA showing rFEF: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D). 
Figure 33 
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Differences between the means (+sem) of the FA of the aIPS for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 33A. DAN ANCOVA showing laIPS: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D). 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 33B. DAN ANCOVA showing  raIPS: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D). 
 
 
Figure 34  
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Differences between the means (+sem) of the FA of the pIPS for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 34A. DAN ANCOVA showing lpIPS: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D). 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 34B. DAN ANCOVA showing rpIPS: Adjacent pairwise group differences (N-K): (HC = PD-N = 
PD-MCI = PD-D). 
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Figure 35 
 
Differences between the means (+sem) of the FA of the MT+ for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 35A. DAN ANCOVA showing lMT+: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D). 
HC PD-N PD-MCI PD-D
Group
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Fig 35B. DAN ANCOVA showing rMT+: Pairwise group differences (N-K): (HC = PD-N = PD-MCI 
= PD-D). 
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Figure 36 
 
Differences between the means (+sem) of the FA of the ACC for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 36A. SN ANCOVA showing lACC: Pairwise group differences (N-K): HC = PD-N = PD-MCI, 
(PD-N = PD-MCI) < PD-D. 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 36B. SN ANCOVA showing rACC: Pairwise group differences (N-K): (HC = PD-N = PD-MCI = 
PD-D). 
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Figure 37  
 
Differences between the means (+sem) of the FA of the INS for the four groups controlling 
for age and education. 
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Fig 37A. SN ANCOVA showing lINS: Pairwise group differences (N-K): (HC = PD-N) < PD-D, (HC 
= PD-N) < PD-MCI, PD-MCI < PD-D. 
HC PD-N PD-MCI PD-D
Group
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F
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Fig 37B. SN ANCOVA showing rINS: Pairwise group differences (N-K): (HC = PD-N = PD-MCI = 
PD-D). 
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Figure 38 
 
Differences between the means (+sem) of the FA of the dlPFC for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 38A. CEN ANCOVA showing ldlPFC: Pairwise group differences (N-K): (HC = PD-N = PD-
MCI = PD-D). 
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Fig 38B. CEN ANCOVA showing rdlPFC: Pairwise group differences (N-K): (HC = PD-N = PD-D = 
PD-MCI). 
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Figure 39  
 
Differences between the means (+sem) of the FA of the aIPL for the four groups controlling 
for age and education. 
 
HC PD-N PD-MCI PD-D
Group
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Fig 39A. CEN ANCOVA showing laIPL: Pairwise group differences (N-K): (HC = PD-N) < PD-D, 
(HC = PD-N = PD-MCI), PD-MCI < PD-D. 
HC PD-N PD-MCI PD-D
Group
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Fig 39B. CEN ANCOVA showing raIPL: Pairwise group differences (N-K): (HC = PD-N = PD-D = 
PD-MCI. 
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As shown in Table 31, age had no significant effect on any ROI except the right pIPL 
of the DMN. Education had no effect on any ROI, except the right INS of the SN and left 
pIPS of the DAN. 
      Significant group main effects were found in the left PCC of the DMN, the left FEF 
of the DAN, and the left INS of the SN. The group main effects for all other ROIs in the four 
networks were not significant. Post-hoc N-K tests revealed that the PD-D group had 
significantly higher FA values than the HC and PD-N group for left FEF, left INS, and left 
aIPL of the CEN, and higher value than the PD-N group only for the left ACC of the SN. The 
PD-D group also had significantly higher FA values than the PD-MCI group for the left 
ACC, left INS, and left aIPL. The PD-MCI group had significantly lower FA values than the 
HC and PD-N group for the left INS, and lower FA values than the HC group only for the left 
PCC. No significant differences were found between the PD-N and HC group for the left 
PCC, left FEF, left ACC, left INS, and left aIPL. There were no significant group differences 
in any other ROI across the four networks. 
      In summary, the PD-D group had higher FA value when compared to the HC or PD-N 
group, for a few nodes in the left hemisphere across the four networks, specifically the left 
FEF, left INS, left aIPL, and left ACC. However, the PD-MCI group, revealed an opposite 
change, with lower values compared to the HC and PD-N group, for some of these nodes. 
Two comments are relevant; first, only a few differences were apparent for FA, and lack of 
consistency may thus reflect some chance variation; secondly, voxels were selected using 
criteria to minimize white matter, so MD changes rather than FA changes might be expected 
to be more reliable measures of between group differences.  
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3.3 ANCOVA GM 
 
ANCOVA (with age and education as covariates) and the Newman-Keuls post-hoc 
comparison tests were performed on the mean values of the Grey Matter (GM) voxels for 
each participant group in a particular ROI for each RSN. The GM voxels are the number of 
voxels identified in individuals in native space after removal of voxels reaching criteria for CSF and 
WM. 
The ANCOVA for the group main effects for GM in the left and right ROIs of the 
four networks are summarized on Table 32 and the mean values for the four participant 
groups for each ROI in every RSN are shown in Figure 40 to Figure 52. The Newman-Keuls 
Test tables are presented in the Appendix.  
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Table 32 
Grey Matter Voxels: Group main effect for the ANCOVA for each ROI for the four cognitive networks         
  dlPFC aIPL 
      
  Left Right Left Right 
      
CEN 
F (3,135) = 
1.48,  p = .2 
F (3,135) = 
2.0, p=.1 
F (3,135) = 
3.6, p=.016 
F (3,135) = 
2.04, p=.1       
          
      
  ACC INS 
      
  Left Right Left Right 
      
SN 
F (3,135) = 
.58, p=.6 
F (3,135) = 
1.44, p=.2 
F (3,135) = 
.62, p=.6 
F (3,135) = 
.1.95, p =.1       
          
      
        FEF aIPS pIPS MT+ 
  
  Left Right Left Right Left Right Left Right 
  
DAN  
F (3,135) = 
1.6, p = .2 
F (3,135) = 
1.17, p=.3 
F (3,135) = 
2.52, p=.1 
F (3,135) = 
3.74, p<.01 
F (3,135) = 
1.03, p=.4 
F (3,135) = 
.93, p=.5 
F (3,135) = 
.62, p=.6 
F (3,135) = 
.377, p=.8   
                  
  
          PCC dMPFC vMPFC pIPL MTG 
  Left Right Left Right Left Right Left Right Left  Right 
DMN  
F (3,135) = 
2.7, p <.049 
F (3,135) = 
.86, p=.5 
F (3,135) = 
2.8, p<.04 
F (3,135) = 
.72, p=.5 
F (3,135) = 
1.8, p=.1 
F (3,135) = 
.29, p=.8 
F (3,135) = 
1.08, p=.4 
F (3,135) = 
.38, p=.8 
F (3,135) = 
1.72, p=.2 
F (3,135) = 
1.8, p=.2 
                      
All bolded F-ratios are significant. Age and education of participants were used as co-variates; age was significant (p<0.05), for the right dMPFC and left 
vMPFC in the DMN. Age was not significant for all other ROIs except the right aIPS of the DAN, and left aIPL for CEN; education was not significant 
for any ROI except right dMPFC of the DMN and the right ACC and left INS of the SN. For abbreviations, see Table 5. 
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Figure 40  
 
Differences between the means (±sem) of the GM voxels of the PCC for the four groups 
controlling for age and education. 
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Fig 40A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing lPCC: Pairwise group differences (N-
K): (HC = PD-N = PD-D), (HC = PD-N = PD-MCI), PD-MCI <PD-D.  
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Fig 40B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing rPCC: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D). 
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Figure 41 
 
Differences between the means (±sem) of the GM voxels of the dMPFC for the four groups 
controlling for age and education. 
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Fig 41A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing ldMPFC: Pairwise group differences 
(N-K): (HC = PD-MCI = PD-D), (PD-N = PD-MCI = PD-D), HC < PD- N. 
HC PD-N PD-MCI PD-D
Group
130
135
140
145
150
155
160
165
170
G
re
y
 M
a
tt
e
r 
V
o
x
e
l
 
Fig 41B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing rdMPFC: Pairwise group differences 
(N-K): (HC = PD-MCI = PD-D), (PD-N = PD-MCI = PD-D), HC < PD- N. 
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Figure 42  
 
Differences between the means (±sem) of the GM voxels of the vMPFC for the four groups 
controlling for age and education. 
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Fig 42A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing lvMPFC: Pairwise group differences 
(N-K): (HC = PD-N = PD-MCI = PD-D) 
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Fig 42B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing rvMPFC: Pairwise group differences 
(N-K): (HC = PD-N = PD-MCI = PD-D. 
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Figure 43 
 
Differences between the means (+sem) of the GM voxels of the pIPL for the four groups 
controlling for age and education. 
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Fig 43A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing lpIPL: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D) 
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Fig 43B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing rpIPL: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D. 
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Figure 44 
 
Differences between the means (+sem) of the GM voxels of the MTG for the four groups 
controlling for age and education. 
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Fig 44A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing lMTG: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D) 
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Fig 44B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DMN ANCOVA showing rMTG: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D). 
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Figure 45  
 
Differences between the means (+sem) of the GM voxels of the FEF for the four groups 
controlling for age and education. 
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Fig 45A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM).  DAN ANCOVA showing lFEF: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D) 
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Fig 45B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DAN ANCOVA showing rFEF: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D. 
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Figure 46 
 
Differences between the means (+sem) of the GM voxels of the aIPS for the four groups 
controlling for age and education. 
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Fig 46A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DAN ANCOVA showing laIPS: Pairwise group differences (N-
K): (HC = PD-N < PD-MCI), (HC = PD-N = PD-D), (PD-MCI = PD-D). 
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Fig 46B. (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DAN ANCOVA showing raIPS: Pairwise group differences (N-
K): (HC = PD-N < PD-MCI = PD-D). 
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Figure 47  
 
Differences between the means (+sem) of the GM voxels of the pIPS for the four groups 
controlling for age and education. 
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Fig 47A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM).  DAN ANCOVA showing lpIPS: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D). 
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Fig 47B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM).  DAN ANCOVA showing rpIPS: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D). 
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Figure 48  
 
Differences between the means (+sem) of the GM voxels of the MT+ for the four groups 
controlling for age and education. 
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Fig 48A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DAN ANCOVA showing lMT+: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D). 
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Fig 48B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). DAN ANCOVA showing rMT+: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D). 
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Figure 49  
 
Differences between the means (+sem) of the GM voxels of the ACC for the four groups 
controlling for age and education. 
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Fig 49A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). SN ANCOVA showing lACC: Pairwise group differences (N-K): 
(HC = PD-N = PD-MCI = PD-D). 
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Fig 49B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). SN ANCOVA showing rACC: Pairwise group differences (N-K): 
(HC = PD-N = PD-MCI = PD-D). 
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Figure 50 
 
Differences between the means (+sem) of the GM voxels of the INS for the four groups 
controlling for age and education. 
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Fig 50A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). SN ANCOVA showing lINS: Pairwise group differences (N-K): 
(HC = PD-N = PD-MCI = PD-D). 
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Fig 50B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). SN ANCOVA showing rINS: Pairwise group differences (N-K): 
HC < PD-N, (HC = PD-MCI = PD-D), PD-N <PD-MCI = PD-D, PD-N < PD-D. 
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Figure 51  
 
Differences between the means (+sem) of the GM voxels of the dlPFC for the four groups 
controlling for age and education. 
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Fig 51A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM) CEN ANCOVA showing ldlPFC: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D). 
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Fig 51B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). CEN ANCOVA showing rdlPFC: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D) 
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Figure 52  
 
Differences between the means (+sem) of the GM voxels of the aIPL for the four groups 
controlling for age and education. 
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Fig 52A (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). CEN ANCOVA showing laIPL: Pairwise group differences (N-
K): (HC = PD-N) <PD-MCI, (HC = PD-N = PD-D), PD-MCI <PD-D. 
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Fig 52B (these are number of voxels identified in individuals in native space after removal of voxels 
reaching criteria for CSF and WM). CEN ANCOVA showing raIPL: Pairwise group differences (N-
K): (HC = PD-N = PD-MCI = PD-D). 
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ANCOVA GM VOXEL NUMBER for the ROIs 
 
The ANCOVA for the group main effects for GM voxel number in the left and right 
ROIs of the four networks are summarized on Table X and the mean values for the four 
participant groups for each ROI are shown in Fig. X. As shown in Table X, age had no 
significant effect on the ROIs of the DMN except the right dMPFC and left vMPFC. Age was 
significant for some other ROIs except the left and right MT+ for DAN, left and right ACC 
for SN, and the right dlPFC and right aIPL for the CEN. Education had no effect for any ROI 
except the right ACC and left INS of the SN, as well as the right dMPFC of the DMN.  
Significant group main effects were found in the left PCC and left dMPFC of the 
DMN, the right aIPS of the DAN, and the left aIPL of the CEN. The group main effects for 
all other ROIs in the four networks were not significant. On the whole, then, relatively few 
reliable differences emerged across the groups in terms of the number of voxels analysed  for 
MD and FA across the groups for the ROIs of the four networks. 
Post-hoc N-K tests revealed that the PD-D group had significantly lower  number of 
grey matter voxels than the HC or PD-N for the right aIPS of the DAN, and lower value 
compared to PD-N only in the right INS of the SN. The PD-D group had significantly higher 
number of grey matter voxels than PD-MCI for the left PCC of the DMN and left aIPL of the 
CEN. The PD-MCI had significantly lower number of grey matter voxel than the HC and PD-
N group for the left and right aIPS of the DAN, and lower value only for the PD-N in the 
right INS of the SN. The PD-N group had significantly higher number of grey matter voxels 
than the HC in the left and right dMPFC, and the right INS. There were no significant group 
differences in any other ROI across the four networks. To summarise, there were relatively 
few consistent differences in GM voxel number for the RSNs across the groups, with the 
direction of these changes varying across ROIs.  
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4. Discussion 
4.1 Summary of Main Findings 
 
 Microstructural integrity of grey matter voxels in key nodes of four cognitive RSN, 
namely the DMN, DAN, SN, and the CEN, was investigated in three groups of patients with 
PD, that differed in terms of their cognitive status. The three patients groups, covering the full 
spectrum of cognitive ability, and were classified as PD-N, with cognition in the normal 
range, PD-MCI, which had cognitive impairment insufficient to cause dementia, and PD-D 
which met criteria for established dementia due to significant deficits in everyday 
independent function. These three PD groups were compared with a matched group of 
healthy controls (HC). The key nodes of the ROIs within these 4 networks were established 
by review of the general literature on RSNs to derive MNI-specified coordinates that were 
then reversed engineered to individual brain DTI images, co-registered to their TI images, so 
that person-specific DTI metrics could be subjected to statistical analysis.   
Based on the mean of MD voxels from the DTI imaging, the PD-D group exhibited 
widespread loss of integrity (higher values) across the most nodes in the RSN, relative to HC 
and PD-N; notable exceptions occurred in the right pIPL of the DMN; the left FEF and right 
IPS of the DAN; and the left aIPL of the CEN, relative to HC only. The PD-MCI showed 
limited selective loss and the PD group with relatively preserved cognition (PD-N) had no 
detectable or minimal loss compared to the HC group.  
Changes in the structural integrity for the RSNs in the PD-MCI group were found to 
be similar to the changes in the PD-D group, and worse than the structural integrity of the HC 
and PD-N group, in the left PCC and left MTG of the DMN, left and right ACC of the SN, 
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and right dlPFC of the CEN; but worse than PD-N only in the left INS of the SN and right 
MT+ of the DAN; worse than HC only, in the left IPL of the DMN. 
The PD-MCI group showed improved structural integrity, when compared with PD-
D, and displayed similar structural integrity to the HC and PD-N group, in the left and right 
dMPFC, right PCC, right vMPFC, and the right MTG of the DMN; and the right FEF, right 
aIPS, and left MT+ of the DAN. 
The PD-N group had no detectable change of structural integrity, relative to HC, in all 
ROIs, across the 4 RSN.  
 For PD-D, it was expected that the DMN would most likely show the greatest change, 
as observed from past studies that have reported the effects of AD dementia, which has been 
shown to follow a disease pattern of brain atrophy that is also evident in PD (Weintraub et al., 
2011). The current study confirmed this hypothesis by showing that the structural integrity 
for the PD-D group was consistently worse across the ROIs of the DMN in comparison with 
the PD-N and HC groups for the DMN. 
This finding was consistent with previous functional magnetic resonance imaging 
(fMRI) connectivity studies that reported the regions of the DMN as a hub of sensitive 
microstructural change during the progression of dementia (Buckner et al., 2008; Brier et al., 
2012; Broyd et al., 2009; Wen et al., 2013). The dysfunction of the DMN observed in the PD-
D group showed similar patterns of DMN impairment in other dementias as well, particularly 
in AD studies (Broyd et al., 2009; Weintraub et al, 2012; Wu et al., 2011). Hence, damage to 
the DMN as a result of PD-D may have a role in the development of cognitive decline in PD, 
similar to AD. Prior PD studies on the effect of PD in DMN support this theory. Decreased 
FC in regions of the DMN in PD patients, specifically the PCC, IPL, and the MPFC has been 
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reported (Rektorova, Krajcociva, Marecek, & Miki, 2012; Tessitore et al., 2012; Van 
Eimeren et al., 2009) 
The structural integrity of the ROIs across the 4 RSNs in PD-MCI could also suggest 
which nodes are likely to be most vulnerable when MCI occurs in PD. In particular, some 
ROIs of the DMN in PD-MCI were found to be similar to HC or PD-N group but others 
relatively similar to PD-D. 
The structural integrity for the PD-N group across the 4 RSN show that it stays 
relatively intact, similar to the structural integrity of the HC group, paralleling previous 
studies using voxel-based morphometry (VBM), a neuroimaging technique that uses statistics 
to investigate the focal differences in brain anatomy (Whitwell, 2009), that shows there is 
little significant structural GM difference between cognitively unimpaired PD patients and 
HC. That is, PD patients, with generally intact cognitive ability (PD-N) also have generally 
intact GM cortical brain tissues (Melzer et. al., 2012; Tessitore et al., 2012; Weintraub et al., 
2011). However, failure to show structural changes in PD may still mean that these patients 
have some functional deficits and indeed compensatory increases in network function.  
The findings described above only reflect changes based on the evaluation of the MD 
values for the ROIs in the 4 RSN, and not on the FA values. The evaluation of the FA values 
in a few ROIs paradoxically suggested that PD-D group seemed to have better structural 
integrity than the ROIs in the other groups, indicated by higher FA values, which contradicts 
the findings observed from the assessment of the MD values. However, this discrepancy may 
be explained by chance variation, as the FA values were inconsistent across the 4 RSN,  and 
by the criteria of the current study which minimized white matter voxels in order to study the 
grey matter voxels. Therefore, MD changes rather than FA changes would be expected to be 
a more consistent measure of group differences in the current study. This suggestion is 
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supported by Schwarz et al. (2013) that showed the FA as an inconsistent measure of the 
structural changes in PD, and MD as a more reliable measure to reveal microstructural 
changes, in a meta-analysis that investigated the DTI imaging of nigral degeneration. 
 The number of grey matter (GM) voxels analyzed for FA and MD was also 
investigated in the current study. It was shown that there were few reliable differences and 
changes were inconsistent across the groups, with the direction of these changes varying 
across ROIs. This similarity suggests that the reduction in MD for many ROIs in PD-D and 
for some nodes in PD-MCI reflect subtle structural change rather than whole-brain 
degeneration. Similarly, standard VBM analyses of T1 images from the whole brain suggest 
widespread GM degeneration in PD-D, in the temporal, parietal, and frontal cortex, which 
reaches statistical significance to a lesser extent in PD-MCI (Melzer et al., 2012). DTI 
imaging is more sensitive to microstructural changes than is T1. 
 The current study revealed that the microstructural changes in the ROIs of the 4 RSN 
were affected differently, depending on the cognitive status of participants. PD-D, in 
particular, showed degeneration of structural integrity in the ROIs across the 4 RSNs, and this 
finding was anticipated by the current study. However, the structural integrity of the ROIs in 
the PD-MCI group across the 4 RSNs did not change as expected, as the integrity of many 
ROIs was found to be similar to the integrity in the HC or PD-N group, which could signify 
those ROIs staying relatively intact in MCI or that the lack of structural changes in these 
ROIs shows it to be less sensitive to the MCI pathology. The PD-N group fails to show any 
significant structural changes in any ROIs across the 4 RSN, indicating that perhaps, PD 
patients retain structural integrity of the ROIs in the early stages of the disease before it 
converts to PD-MCI or PD-D. This finding can also be explained by the lack of sensitivity to 
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functional changes or compensation. Nonetheless, the current study showed that the 
microstructural changes in the RSNs of PD patients are clearly influenced by cognitive status. 
4.2 Limitations and Future Directions 
 
 The current study evaluated structural changes of the ROIs in the RSNs, which could 
imply functional changes such as cognition or behavior as a result of PD. Dagher & Nagano-
Saito (2007) stated that cognition in PD could be explained by direct neuronal loss in medial 
temporal and lateral prefrontal areas as a result of PD. Ibarretxe-Barrao, Tolosa, Junque, & 
Marti (2009) showed that lower hippocampal volume in patients with PD, relative to HC, 
correlated with deficits in verbal memory. Similarly, Biundo et al. (2011) also showed that 
brain atrophy in the middle and superior frontal gyrus in patients with PD leads to the 
development of implusive behaviours and in worse working memory. In a study of functional 
integrity of DMN in cognitively unimpaired PD patients, Tessitore et al. (2012) reported that 
there was a functional disruption of the DMN, in the absence of any significant structural 
differences, which showed that structural changes are not necessarily a pre-requisite for 
functional changes in PD.  Nonetheless, the current study have shown significant structural 
changes in PD-D, which would imply that functional connectivity in those RSNs would be 
compromised; in PD-MCI, the more subtle changes could have a major impact on cognition 
or be compensated, the answer to which would require a combined structural / functional 
study. The changes observed in a combined study would suggest that interventions, such as 
cognitive training, could improve or delay the onset of cognitive impairment. 
 This study has included a comparison of the main nodes in the 4 RSN, but owing to 
time constraints, no association with any cognitive measures in the five cognitive domains 
was undertaken. Although it is possible to see the cognitive differences between groups based 
on the global cognitive domain Z scores as well as the individual Z scores for every cognitive 
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domain except language, statistical comparisons with individual cognitive tests and DTI 
measures could might reveal interesting associations. The sample size of the participants in 
the current study might also be an issue. There were relatively low numbers of participants, 
per group, with the exception of the PD-N group. Future research should ensure that there is a 
higher number of participants across all groups and examine the association between 
individual cognitive tests and the main nodes explored fully. 
 An issue with the current study was that it utilized Movement Disorders Task Force 
criteria for the diagnosis of MCI in PD participants remains uncertain, because they were not 
yet fully validated. Although consistent with the criteria suggested by Litvan et al. (2012) for 
the diagnosis of MCI in PD patients, more limited criteria were specified for PD-MCI in the 
current study. There is evidence that our specific criteria, as used in the current study, have 
done well in predicting conversion to PD-D and may be superior to many alternatives in that 
regard (Dalrymple-Alford, 2013; Wood et al., 2013). That is, diagnosis of MCI in PD patients 
used in the current study are likely to pick up many patients who are at high risk of 
conversion to dementia in the following 3 years, which the potential value for the ROI 
changes identified here.  
4.3 Concluding Remarks 
 
 This study examined microstructural integrity of ROIs in four key brain networks, the 
DMN, DAN, SN, and CEN, in 3 groups of participants with PD, namely PD-N, PD-MCI, and 
PD-D, and a comparison group of healthy controls. The PD-D group was found to have the 
worse structural integrity for most ROIs across all the RSNs, relative to all groups. The 
structural integrity of the ROIs in the PD-MCI group showed selective change in some ROIs, 
but was similar to the structural integrity of the PD-N group or PD-D group in many ROIs. 
The PD-N group had no detectable or minimal change in the structural integrity of all the 
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ROIs across the four RSN, relative to healthy controls. The unique findings of this current 
study showed that subtle structural changes are evident in the RSNs, when patients reach a 
PD-MCI condition and that clear deficits in many regions are evident in PD-D. For future 
study, structural and functional changes for these RSNs should be explored to examine 
similarities between both measures. 
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Appendix 1: Newman-Keuls Tests 
DMN Newman-Keuls Test 
DMN Newman-Keuls Test (lPCC) 
FA 
Newman-Keuls test; variable FA (lPCC) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00039, df = 135.00 
 
Group {1} - .15179 {2} - .14318 {3} - .13613 {4} - .14729 
1 HC 
 
0.226863 0.014705 0.389822 
2 PD-N 0.226863 
 
0.177808 0.432517 
3 PD-MCI 0.014705 0.177808 
 
0.083379 
4 PD-D 0.389822 0.432517 0.083379 
 
*red = significant, p <0.05 
MD 
Newman-Keuls test; variable MD (lPCC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00090 {2} - .00091 {3} - .00098 {4} - .00100 
1 HC 
 
0.748937 0.003110 0.000087 
2 PD-N 0.748937 
 
0.003196 0.000184 
3 PD-MCI 0.003110 0.003196 
 
0.280764 
4 PD-D 0.000087 0.000184 0.280764 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (lPCC GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 723.07, df = 135.00 
 
Group {1} - 139.35 {2} - 136.97 {3} - 131.39 {4} - 150.83 
1 HC 
 
0.736576 0.500129 0.105607 
2 PD-N 0.736576 
 
0.431802 0.123647 
3 PD-MCI 0.500129 0.431802 
 
0.031175 
4 PD-D 0.105607 0.123647 0.031175 
 
*red = significant, p <0.05 
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DMN Newman-Keuls Test (rPCC) 
FA 
Newman-Keuls test; variable FA (rPCC) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00039, df = 135.00 
 
Group {1} - .14596 {2} - .13997 {3} - .13552 {4} - .14383 
1 HC 
 
0.481684 0.184262 0.682110 
2 PD-N 0.481684 
 
0.391360 0.457452 
3 PD-MCI 0.184262 0.391360 
 
0.245513 
4 PD-D 0.682110 0.457452 0.245513 
 
 
MD 
Newman-Keuls test; variable MD (rPCC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00092 {2} - .00091 {3} - .00096 {4} - .00103 
1 HC 
 
0.743895 0.078061 0.000030 
2 PD-N 0.743895 
 
0.092138 0.000011 
3 PD-MCI 0.078061 0.092138 
 
0.003751 
4 PD-D 0.000030 0.000011 0.003751 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rPCC GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 789.51, df = 135.00 
 
Group {1} - 135.90 {2} - 143.39 {3} - 138.82 {4} - 147.44 
1 HC 
 
0.570382 0.693778 0.403349 
2 PD-N 0.570382 
 
0.537572 0.584411 
3 PD-MCI 0.693778 0.537572 
 
0.475121 
4 PD-D 0.403349 0.584411 0.475121 
 
 
 
 
 
 
 
189 | P a g e  
 
DMN Newman-Keuls Test (ldMPFC) 
FA 
Newman-Keuls test; variable FA (ldMPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00060, df = 135.00 
 
Group {1} - .15385 {2} - .15266 {3} - .14990 {4} - .15358 
1 HC 
 
0.981673 0.928661 0.967236 
2 PD-N 0.981673 
 
0.668874 0.886984 
3 PD-MCI 0.928661 0.668874 
 
0.836192 
4 PD-D 0.967236 0.886984 0.836192 
 
 
MD 
Newman-Keuls test; variable MD (ldMPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00111 {2} - .00109 {3} - .00117 {4} - .00139 
1 HC 
 
0.794308 0.283000 0.000028 
2 PD-N 0.794308 
 
0.376057 0.000011 
3 PD-MCI 0.283000 0.376057 
 
0.000279 
4 PD-D 0.000028 0.000011 0.000279 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (ldMPFC GM) Approximate Probabilities 
for Post Hoc Tests Error: Between MSE = 977.65, df = 135.00 
 
Group {1} - 128.32 {2} - 150.67 {3} - 142.93 {4} - 140.33 
1 HC 
 
0.034034 0.179408 0.145321 
2 PD-N 0.034034 
 
0.347802 0.421684 
3 PD-MCI 0.179408 0.347802 
 
0.753023 
4 PD-D 0.145321 0.421684 0.753023 
 
*red = significant, p <0.05 
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DMN Newman-Keuls Test (rdMPFC) 
FA 
Newman-Keuls test; variable FA (rdMPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00053, df = 135.00 
 
Group {1} - .14966 {2} - .16002 {3} - .15044 {4} - .15211 
1 HC 
 
0.323966 0.897758 0.914454 
2 PD-N 0.323966 
 
0.258327 0.194801 
3 PD-MCI 0.897758 0.258327 
 
0.783864 
4 PD-D 0.914454 0.194801 0.783864 
 
 
MD 
Newman-Keuls test; variable MD (rdMPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00109 {2} - .00101 {3} - .00111 {4} - .00125 
1 HC 
 
0.096302 0.699037 0.004231 
2 PD-N 0.096302 
 
0.100573 0.000015 
3 PD-MCI 0.699037 0.100573 
 
0.005255 
4 PD-D 0.004231 0.000015 0.005255 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rdMPFC GM) Approximate Probabilities 
for Post Hoc Tests Error: Between MSE = 934.06, df = 135.00 
 
Group {1} - 146.65 {2} - 159.27 {3} - 148.68 {4} - 142.06 
1 HC 
 
0.260690 0.800878 0.569142 
2 PD-N 0.260690 
 
0.189094 0.142098 
3 PD-MCI 0.800878 0.189094 
 
0.689638 
4 PD-D 0.569142 0.142098 0.689638 
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DMN Newman-Keuls Test (lvMPFC) 
FA 
Newman-Keuls test; variable FA (lvMPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00089, df = 135.00 
 
Group {1} - .17875 {2} - .17017 {3} - .16153 {4} - .16793 
1 HC 
 
0.274596 0.124985 0.352071 
2 PD-N 0.274596 
 
0.513456 0.774727 
3 PD-MCI 0.124985 0.513456 
 
0.415218 
4 PD-D 0.352071 0.774727 0.415218 
 
 
MD 
Newman-Keuls test; variable MD (lvMPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00097 {2} - .00096 {3} - .00101 {4} - .00105 
1 HC 
 
0.681381 0.123128 0.017492 
2 PD-N 0.681381 
 
0.124257 0.009187 
3 PD-MCI 0.123128 0.124257 
 
0.235257 
4 PD-D 0.017492 0.009187 0.235257 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (lvMPFC GM) Approximate Probabilities 
for Post Hoc Tests Error: Between MSE = 865.18, df = 135.00 
 
Group {1} - 156.00 {2} - 169.83 {3} - 159.11 {4} - 170.83 
1 HC 
 
0.175519 0.688809 0.222958 
2 PD-N 0.175519 
 
0.167036 0.896925 
3 PD-MCI 0.688809 0.167036 
 
0.285516 
4 PD-D 0.222958 0.896925 0.285516 
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DMN Newman-Keuls Test (rvMPFC) 
FA 
Newman-Keuls test; variable FA (rvMPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00089, df = 135.00 
 
Group {1} - .17737 {2} - .16616 {3} - .16149 {4} - .16263 
1 HC 
 
0.154973 0.182364 0.147160 
2 PD-N 0.154973 
 
0.824003 0.653612 
3 PD-MCI 0.182364 0.824003 
 
0.885496 
4 PD-D 0.147160 0.653612 0.885496 
 
 
MD 
Newman-Keuls test; variable MD (rvMPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00093 {2} - .00095 {3} - .00100 {4} - .00106 
1 HC 
 
0.541335 0.028843 0.000021 
2 PD-N 0.541335 
 
0.052200 0.000138 
3 PD-MCI 0.028843 0.052200 
 
0.030693 
4 PD-D 0.000021 0.000138 0.030693 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rvMPFC GM) Approximate Probabilities 
for Post Hoc Tests Error: Between MSE = 981.68, df = 135.00 
 
Group {1} - 162.58 {2} - 165.44 {3} - 156.64 {4} - 155.89 
1 HC 
 
0.729597 0.472475 0.697012 
2 PD-N 0.729597 
 
0.536414 0.655060 
3 PD-MCI 0.472475 0.536414 
 
0.927318 
4 PD-D 0.697012 0.655060 0.927318 
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DMN Newman-Keuls Test (lpIPL) 
FA 
Newman-Keuls test; variable FA (lpIPL) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00035, df = 135.00 
 
Group {1} - .14024 {2} - .13390 {3} - .13908 {4} - .13543 
1 HC 
 
0.566370 0.811973 0.587610 
2 PD-N 0.566370 
 
0.541096 0.755397 
3 PD-MCI 0.811973 0.541096 
 
0.456198 
4 PD-D 0.587610 0.755397 0.456198 
 
 
MD 
Newman-Keuls test; variable MD (lpIPL) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00098 {2} - .00101 {3} - .00105 {4} - .00108 
1 HC 
 
0.225964 0.034843 0.001886 
2 PD-N 0.225964 
 
0.203478 0.045611 
3 PD-MCI 0.034843 0.203478 
 
0.267832 
4 PD-D 0.001886 0.045611 0.267832 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (lpIPL GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1780.5, df = 135.00 
 
Group {1} - 212.26 {2} - 209.17 {3} - 193.46 {4} - 205.72 
1 HC 
 
0.781572 0.329689 0.826982 
2 PD-N 0.781572 
 
0.335031 0.756618 
3 PD-MCI 0.329689 0.335031 
 
0.270758 
4 PD-D 0.826982 0.756618 0.270758 
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DMN Newman-Keuls Test (rpIPL) 
FA 
Newman-Keuls test; variable FA (rpIPL) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00024, df = 135.00 
 
Group {1} - .13865 {2} - .13449 {3} - .13844 {4} - .14021 
1 HC 
 
0.571985 0.960657 0.705054 
2 PD-N 0.571985 
 
0.337883 0.507986 
3 PD-MCI 0.960657 0.337883 
 
0.904035 
4 PD-D 0.705054 0.507986 0.904035 
 
 
MD 
Newman-Keuls test; variable MD (rpIPL) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00097 {2} - .00096 {3} - .00099 {4} - .00102 
1 HC 
 
0.718963 0.344978 0.117304 
2 PD-N 0.718963 
 
0.392774 0.089297 
3 PD-MCI 0.344978 0.392774 
 
0.300673 
4 PD-D 0.117304 0.089297 0.300673 
 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rpIPL GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1576.8, df = 135.00 
 
Group {1} - 230.90 {2} - 239.95 {3} - 231.11 {4} - 223.39 
1 HC 
 
0.663032 0.984480 0.473124 
2 PD-N 0.663032 
 
0.398371 0.389231 
3 PD-MCI 0.984480 0.398371 
 
0.741541 
4 PD-D 0.473124 0.389231 0.741541 
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DMN Newman-Keuls Test (lMTG) 
FA 
Newman-Keuls test; variable FA (lMTG) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00048, df = 135.00 
 
Group {1} - .16427 {2} - .15896 {3} - .16240 {4} - .16461 
1 HC 
 
0.629250 0.747572 0.953415 
2 PD-N 0.629250 
 
0.551455 0.763228 
3 PD-MCI 0.747572 0.551455 
 
0.923390 
4 PD-D 0.953415 0.763228 0.923390 
 
 
MD 
Newman-Keuls test; variable MD (lMTG) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00097 {2} - .00098 {3} - .00105 {4} - .00109 
1 HC 
 
0.836770 0.036467 0.000474 
2 PD-N 0.836770 
 
0.023865 0.000542 
3 PD-MCI 0.036467 0.023865 
 
0.137320 
4 PD-D 0.000474 0.000542 0.137320 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (lMTG GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1493.3, df = 135.00 
 
Group {1} - 235.52 {2} - 234.58 {3} - 221.64 {4} - 244.83 
1 HC 
 
0.926686 0.361531 0.360687 
2 PD-N 0.926686 
 
0.204432 0.572992 
3 PD-MCI 0.361531 0.204432 
 
0.103842 
4 PD-D 0.360687 0.572992 0.103842 
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DMN Newman-Keuls Test (rMTG) 
FA 
Newman-Keuls test; variable FA (rMTG) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00038, df = 135.00 
 
Group {1} - .15911 {2} - .15697 {3} - .16080 {4} - .15869 
1 HC 
 
0.907974 0.740961 0.934471 
2 PD-N 0.907974 
 
0.877073 0.736651 
3 PD-MCI 0.740961 0.877073 
 
0.910352 
4 PD-D 0.934471 0.736651 0.910352 
 
 
MD 
Newman-Keuls test; variable MD (rMTG) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00097 {2} - .00098 {3} - .00101 {4} - .00108 
1 HC 
 
0.727986 0.178884 0.000170 
2 PD-N 0.727986 
 
0.154264 0.000375 
3 PD-MCI 0.178884 0.154264 
 
0.015689 
4 PD-D 0.000170 0.000375 0.015689 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rMTG GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1623.4, df = 135.00 
 
Group {1} - 239.23 {2} - 252.69 {3} - 235.89 {4} - 258.56 
1 HC 
 
0.205284 0.753829 0.163400 
2 PD-N 0.205284 
 
0.254173 0.580854 
3 PD-MCI 0.753829 0.254173 
 
0.142843 
4 PD-D 0.163400 0.580854 0.142843 
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DAN Newman-Keuls 
Newman-Keuls Test (lFEF) 
FA 
Newman-Keuls test; variable FA (lFEF) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00026, df = 135.00 
 
Group {1} - .13438 {2} - .13245 {3} - .13287 {4} - .15048 
1 HC 
 
0.893701 0.724351 0.000174 
2 PD-N 0.893701 
 
0.921206 0.000151 
3 PD-MCI 0.724351 0.921206 
 
0.000131 
4 PD-D 0.000174 0.000151 0.000131 
 
*red = significant, p <0.05 
MD 
Newman-Keuls test; variable MD (lFEF) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00000, df = 135.00 
 
Group {1} - .00105 {2} - .00104 {3} - .00104 {4} - .00110 
1 HC 
 
0.975778 0.939967 0.103768 
2 PD-N 0.975778 
 
0.892127 0.255516 
3 PD-MCI 0.939967 0.892127 
 
0.204317 
4 PD-D 0.103768 0.255516 0.204317 
 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (lFEF GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1388.2, df = 135.00 
 
Group {1} - 208.16 {2} - 210.56 {3} - 195.86 {4} - 216.67 
1 HC 
 
0.806996 0.210586 0.662140 
2 PD-N 0.806996 
 
0.292677 0.534532 
3 PD-MCI 0.210586 0.292677 
 
0.147504 
4 PD-D 0.662140 0.534532 0.147504 
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Newman-Keuls Test (rFEF) 
FA 
Newman-Keuls test; variable FA (rFEF) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00036, df = 135.00 
 
Group {1} - .14802 {2} - .14560 {3} - .14362 {4} - .14945 
1 HC 
 
0.629570 0.655885 0.774522 
2 PD-N 0.629570 
 
0.694306 0.722191 
3 PD-MCI 0.655885 0.694306 
 
0.650994 
4 PD-D 0.774522 0.722191 0.650994 
 
 
MD 
Newman-Keuls test; variable MD (rFEF) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00096 {2} - .00098 {3} - .00102 {4} - .00110 
1 HC 
 
0.603981 0.208785 0.000201 
2 PD-N 0.603981 
 
0.241264 0.000840 
3 PD-MCI 0.208785 0.241264 
 
0.013972 
4 PD-D 0.000201 0.000840 0.013972 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rFEF GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1258.2, df = 135.00 
 
Group {1} - 183.00 {2} - 174.70 {3} - 178.54 {4} - 180.33 
1 HC 
 
0.811760 0.882098 0.775646 
2 PD-N 0.811760 
 
0.682086 0.819155 
3 PD-MCI 0.882098 0.682086 
 
0.847658 
4 PD-D 0.775646 0.819155 0.847658 
 
 
 
 
 
 
 
199 | P a g e  
 
Newman-Keuls Test (laIPS) 
FA 
Newman-Keuls test; variable FA (laIPS) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00018, df = 135.00 
 
Group {1} - .12978 {2} - .12445 {3} - .12487 {4} - .13284 
1 HC 
 
0.285068 0.163047 0.384355 
2 PD-N 0.285068 
 
0.906547 0.080483 
3 PD-MCI 0.163047 0.906547 
 
0.060852 
4 PD-D 0.384355 0.080483 0.060852 
 
 
MD 
Newman-Keuls test; variable MD (laIPS) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00104 {2} - .00109 {3} - .00110 {4} - .00115 
1 HC 
 
0.096404 0.103022 0.000610 
2 PD-N 0.096404 
 
0.706690 0.067220 
3 PD-MCI 0.103022 0.706690 
 
0.064677 
4 PD-D 0.000610 0.067220 0.064677 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (laIPS GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1183.1, df = 135.00 
 
Group {1} - 200.13 {2} - 196.09 {3} - 174.14 {4} - 184.61 
1 HC 
 
0.656492 0.021754 0.201249 
2 PD-N 0.656492 
 
0.041167 0.205659 
3 PD-MCI 0.021754 0.041167 
 
0.248586 
4 PD-D 0.201249 0.205659 0.248586 
 
*red = significant, p <0.05 
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Newman-Keuls Test (raIPS) 
FA 
Newman-Keuls test; variable FA (raIPS) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00027, df = 135.00 
 
Group {1} - .12634 {2} - .12336 {3} - .12561 {4} - .13159 
1 HC 
 
0.769846 0.865558 0.225715 
2 PD-N 0.769846 
 
0.603196 0.227716 
3 PD-MCI 0.865558 0.603196 
 
0.350984 
4 PD-D 0.225715 0.227716 0.350984 
 
 
MD 
Newman-Keuls test; variable MD (raIPS) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00109 {2} - .00109 {3} - .00113 {4} - .00120 
1 HC 
 
0.901400 0.281051 0.001374 
2 PD-N 0.901400 
 
0.162425 0.001128 
3 PD-MCI 0.281051 0.162425 
 
0.031237 
4 PD-D 0.001374 0.001128 0.031237 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (raIPS GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1144.7, df = 135.00 
 
Group {1} - 184.00 {2} - 178.95 {3} - 155.21 {4} - 149.83 
1 HC 
 
0.571731 0.003608 0.000763 
2 PD-N 0.571731 
 
0.007828 0.003172 
3 PD-MCI 0.003608 0.007828 
 
0.546550 
4 PD-D 0.000763 0.003172 0.546550 
 
*red = significant, p <0.05 
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Newman-Keuls Test (lpIPS) 
FA 
Newman-Keuls test; variable FA (lpIPS) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00046, df = 135.00 
 
Group {1} - .13705 {2} - .13629 {3} - .13094 {4} - .13549 
1 HC 
 
0.892256 0.700522 0.958786 
2 PD-N 0.892256 
 
0.610739 0.887996 
3 PD-MCI 0.700522 0.610739 
 
0.420396 
4 PD-D 0.958786 0.887996 0.420396 
 
 
MD 
Newman-Keuls test; variable MD (lpIPS) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00108 {2} - .00107 {3} - .00113 {4} - .00119 
1 HC 
 
0.758543 0.104306 0.001290 
2 PD-N 0.758543 
 
0.129778 0.000782 
3 PD-MCI 0.104306 0.129778 
 
0.058711 
4 PD-D 0.001290 0.000782 0.058711 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (lpIPS GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1376.6, df = 135.00 
 
Group {1} - 169.55 {2} - 170.64 {3} - 153.29 {4} - 151.33 
1 HC 
 
0.911146 0.096582 0.150099 
2 PD-N 0.911146 
 
0.178589 0.198283 
3 PD-MCI 0.096582 0.178589 
 
0.841891 
4 PD-D 0.150099 0.198283 0.841891 
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Newman-Keuls Test (rpIPS) 
FA 
Newman-Keuls test; variable FA (rpIPS) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00034, df = 135.00 
 
Group {1} - .13499 {2} - .13353 {3} - .12799 {4} - .13561 
1 1 
 
0.764671 0.325556 0.900251 
2 2 0.764671 
 
0.258324 0.905368 
3 3 0.325556 0.258324 
 
0.404581 
4 4 0.900251 0.905368 0.404581 
 
 
MD 
Newman-Keuls test; variable MD (rpIPS) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00110 {2} - .00107 {3} - .00114 {4} - .00119 
1 1 
 
0.415107 0.313815 0.068348 
2 2 0.415107 
 
0.162299 0.012990 
3 3 0.313815 0.162299 
 
0.226421 
4 4 0.068348 0.012990 0.226421 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rpIPS GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1210.5, df = 135.00 
 
Group {1} - 154.48 {2} - 164.34 {3} - 141.25 {4} - 147.61 
1 HC 
 
0.282651 0.319327 0.453927 
2 PD-N 0.282651 
 
0.057406 0.161953 
3 PD-MCI 0.319327 0.057406 
 
0.488225 
4 PD-D 0.453927 0.161953 0.488225 
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Newman-Keuls Test (lMT+) 
FA 
Newman-Keuls test; variable FA (lMT+) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00036, df = 135.00 
 
Group {1} - .13000 {2} - .13555 {3} - .13464 {4} - .13245 
1 HC 
 
0.688046 0.627337 0.626020 
2 PD-N 0.688046 
 
0.855631 0.811876 
3 PD-MCI 0.627337 0.855631 
 
0.664932 
4 PD-D 0.626020 0.811876 0.664932 
 
 
MD 
Newman-Keuls test; variable MD (lMT+) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00093 {2} - .00091 {3} - .00096 {4} - .00107 
1 HC 
 
0.423301 0.248856 0.000022 
2 PD-N 0.423301 
 
0.123872 0.000008 
3 PD-MCI 0.248856 0.123872 
 
0.000020 
4 PD-D 0.000022 0.000008 0.000020 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (lMT+ GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1780.5, df = 135.00 
 
Group {1} - 212.26 {2} - 209.17 {3} - 193.46 {4} - 205.72 
1 HC 
 
0.781572 0.329689 0.826982 
2 PD-N 0.781572 
 
0.335031 0.756618 
3 PD-MCI 0.329689 0.335031 
 
0.270758 
4 PD-D 0.826982 0.756618 0.270758 
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Newman-Keuls Test (rMT+) 
FA 
Newman-Keuls test; variable FA (rMT+) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00041, df = 135.00 
 
Group {1} - .13758 {2} - .14011 {3} - .13354 {4} - .13537 
1 HC 
 
0.633727 0.727775 0.678454 
2 PD-N 0.633727 
 
0.603783 0.645958 
3 PD-MCI 0.727775 0.603783 
 
0.730051 
4 PD-D 0.678454 0.645958 0.730051 
 
 
 
MD 
Newman-Keuls test; variable MD (rMT+) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00096 {2} - .00094 {3} - .00101 {4} - .00101 
1 HC 
 
0.444759 0.053002 0.021234 
2 PD-N 0.444759 
 
0.010970 0.006108 
3 PD-MCI 0.053002 0.010970 
 
0.986721 
4 PD-D 0.021234 0.006108 0.986721 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rMT+ GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1576.8, df = 135.00 
 
Group {1} - 230.90 {2} - 239.95 {3} - 231.11 {4} - 223.39 
1 HC 
 
0.663032 0.984480 0.473124 
2 PD-N 0.663032 
 
0.398371 0.389231 
3 PD-MCI 0.984480 0.398371 
 
0.741541 
4 PD-D 0.473124 0.389231 0.741541 
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SN Newman-Keuls 
Newman-Keuls Test (lACC) 
FA 
Newman-Keuls test; variable FA (lACC) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00054, df = 135.00 
 
Group {1} - .16923 {2} - .16541 {3} - .16018 {4} - .17985 
1 HC 
 
0.534482 0.303355 0.083479 
2 PD-N 0.534482 
 
0.393641 0.048959 
3 PD-MCI 0.303355 0.393641 
 
0.007388 
4 PD-D 0.083479 0.048959 0.007388 
 
*red = significant, p <0.05 
 
MD 
Newman-Keuls test; variable MD (lACC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00099 {2} - .00096 {3} - .00105 {4} - .00108 
1 HC 
 
0.292792 0.039634 0.005924 
2 PD-N 0.292792 
 
0.005329 0.000218 
3 PD-MCI 0.039634 0.005329 
 
0.307801 
4 PD-D 0.005924 0.000218 0.307801 
 
*red = significant, p <0.05 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (lACC GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 2297.2, df = 135.00 
 
Group {1} - 238.13 {2} - 241.50 {3} - 239.54 {4} - 256.50 
1 HC 
 
0.961567 0.911414 0.466144 
2 PD-N 0.961567 
 
0.876540 0.235436 
3 PD-MCI 0.911414 0.876540 
 
0.371949 
4 PD-D 0.466144 0.235436 0.371949 
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Newman-Keuls Test (rACC) 
FA 
Newman-Keuls test; variable FA (rACC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00044, df = 135.00 
 
Group {1} - .15722 {2} - .15386 {3} - .15282 {4} - .16615 
1 HC 
 
0.540585 0.703284 0.104807 
2 PD-N 0.540585 
 
0.851176 0.065595 
3 PD-MCI 0.703284 0.851176 
 
0.073043 
4 PD-D 0.104807 0.065595 0.073043 
 
 
MD 
Newman-Keuls test; variable MD (rACC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00092 {2} - .00095 {3} - .00101 {4} - .00105 
1 HC 
 
0.343512 0.002060 0.000009 
2 PD-N 0.343512 
 
0.014760 0.000106 
3 PD-MCI 0.002060 0.014760 
 
0.082214 
4 PD-D 0.000009 0.000106 0.082214 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rACC GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1974.7, df = 135.00 
 
Group {1} - 240.74 {2} - 241.25 {3} - 244.11 {4} - 263.61 
1 1 
 
0.965431 0.955584 0.206879 
2 2 0.965431 
 
0.807443 0.136471 
3 3 0.955584 0.807443 
 
0.096140 
4 4 0.206879 0.136471 0.096140 
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Newman-Keuls Test (lINS) 
FA 
Newman-Keuls test; variable FA (lINS) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00047, df = 135.00 
 
Group {1} - .16424 {2} - .16358 {3} - .15056 {4} - .17245 
1 HC 
 
0.908845 0.043666 0.150281 
2 PD-N 0.908845 
 
0.022485 0.266271 
3 PD-MCI 0.043666 0.022485 
 
0.000744 
4 PD-D 0.150281 0.266271 0.000744 
 
*red = significant, p <0.05 
 
MD 
Newman-Keuls test; variable MD (lINS) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00000, df = 135.00 
 
Group {1} - .00125 {2} - .00120 {3} - .00133 {4} - .00138 
1 HC 
 
0.383973 0.075409 0.018761 
2 PD-N 0.383973 
 
0.022039 0.001997 
3 PD-MCI 0.075409 0.022039 
 
0.354095 
4 PD-D 0.018761 0.001997 0.354095 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rINS GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1343.4, df = 135.00 
 
Group {1} - 194.87 {2} - 215.27 {3} - 189.14 {4} - 185.28 
1 HC 
 
0.034904 0.553526 0.581750 
2 PD-N 0.034904 
 
0.018907 0.010382 
3 PD-MCI 0.553526 0.018907 
 
0.689315 
4 PD-D 0.581750 0.010382 0.689315 
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Newman-Keuls Test (rINS) 
FA 
Newman-Keuls test; variable FA (rINS) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00035, df = 135.00 
 
Group {1} - .15395 {2} - .15512 {3} - .14925 {4} - .14997 
1 HC 
 
0.812395 0.603192 0.416957 
2 PD-N 0.812395 
 
0.629469 0.545863 
3 PD-MCI 0.603192 0.629469 
 
0.883331 
4 PD-D 0.416957 0.545863 0.883331 
 
 
MD 
Newman-Keuls test; variable MD (rINS) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00000, df = 135.00 
 
Group {1} - .00122 {2} - .00117 {3} - .00127 {4} - .00136 
1 HC 
 
0.147853 0.294100 0.002282 
2 PD-N 0.147853 
 
0.033577 0.000016 
3 PD-MCI 0.294100 0.033577 
 
0.021019 
4 PD-D 0.002282 0.000016 0.021019 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rINS GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1343.4, df = 135.00 
 
Group {1} - 194.87 {2} - 215.27 {3} - 189.14 {4} - 185.28 
1 HC 
 
0.034904 0.553526 0.581750 
2 PD-N 0.034904 
 
0.018907 0.010382 
3 PD-MCI 0.553526 0.018907 
 
0.689315 
4 PD-D 0.581750 0.010382 0.689315 
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CEN Newman-Keuls 
Newman-Keuls Test (ldlPFC) 
FA 
Newman-Keuls test; variable FA (ldlPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00041, df = 135.00 
 
Group {1} - .16234 {2} - .15806 {3} - .15804 {4} - .16887 
1 HC 
 
0.421923 0.698809 0.220631 
2 PD-N 0.421923 
 
0.997053 0.105544 
3 PD-MCI 0.698809 0.997053 
 
0.176320 
4 PD-D 0.220631 0.105544 0.176320 
 
 
MD 
Newman-Keuls test; variable MD (ldlPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00107 {2} - .00108 {3} - .00115 {4} - .00121 
1 HC 
 
0.720641 0.065172 0.000252 
2 PD-N 0.720641 
 
0.060243 0.000559 
3 PD-MCI 0.065172 0.060243 
 
0.063173 
4 PD-D 0.000252 0.000559 0.063173 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (ldlPFC GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1059.3, df = 135.00 
 
Group {1} - 183.97 {2} - 186.42 {3} - 190.64 {4} - 191.00 
1 HC 
 
0.774987 0.716846 0.845451 
2 PD-N 0.774987 
 
0.622949 0.854965 
3 PD-MCI 0.716846 0.622949 
 
0.966820 
4 PD-D 0.845451 0.854965 0.966820 
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Newman-Keuls Test (rdlPFC) 
FA 
Newman-Keuls test; variable FA (rdlPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00046, df = 135.00 
 
Group {1} - .16473 {2} - .16588 {3} - .16215 {4} - .16890 
1 HC 
 
0.839386 0.648725 0.741432 
2 PD-N 0.839386 
 
0.787685 0.593091 
3 PD-MCI 0.648725 0.787685 
 
0.631530 
4 PD-D 0.741432 0.593091 0.631530 
 
 
MD 
Newman-Keuls test; variable MD (rdlPFC) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00102 {2} - .00102 {3} - .00107 {4} - .00113 
1 HC 
 
0.984398 0.169722 0.006981 
2 PD-N 0.984398 
 
0.344711 0.012398 
3 PD-MCI 0.169722 0.344711 
 
0.098170 
4 PD-D 0.006981 0.012398 0.098170 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (rdlPFC GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1218.2, df = 135.00 
 
Group {1} - 183.26 {2} - 195.14 {3} - 177.11 {4} - 184.56 
1 HC 
 
0.400416 0.504069 0.887934 
2 PD-N 0.400416 
 
0.203789 0.250252 
3 PD-MCI 0.504069 0.203789 
 
0.697418 
4 PD-D 0.887934 0.250252 0.697418 
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Newman-Keuls Test (laIPL) 
FA 
Newman-Keuls test; variable FA (laIPL) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00025, df = 135.00 
 
Group {1} - .13620 {2} - .14155 {3} - .13775 {4} - .14711 
1 HC 
 
0.407881 0.710993 0.045073 
2 PD-N 0.407881 
 
0.364418 0.183428 
3 PD-MCI 0.710993 0.364418 
 
0.065071 
4 PD-D 0.045073 0.183428 0.065071 
 
*red = significant, p <0.05 
 
MD 
Newman-Keuls test; variable MD (laIPL) Approximate Probabilities for Post Hoc Tests 
Error: Between MSE = .00000, df = 135.00 
 
Group {1} - .00105 {2} - .00102 {3} - .00107 {4} - .00111 
1 HC 
 
0.235731 0.710570 0.200295 
2 PD-N 0.235731 
 
0.264572 0.019614 
3 PD-MCI 0.710570 0.264572 
 
0.179664 
4 PD-D 0.200295 0.019614 0.179664 
 
*red = significant, p <0.05 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (laIPL GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1093.2, df = 135.00 
 
Group {1} - 202.03 {2} - 199.70 {3} - 175.07 {4} - 194.06 
1 HC 
 
0.789444 0.010741 0.631049 
2 PD-N 0.789444 
 
0.013156 0.517282 
3 PD-MCI 0.010741 0.013156 
 
0.029508 
4 PD-D 0.631049 0.517282 0.029508 
 
*red = significant, p <0.05 
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Newman-Keuls Test (raIPL) 
FA 
Newman-Keuls test; variable FA (raIPL) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00022, df = 135.00 
 
Group {1} - .13657 {2} - .13561 {3} - .13632 {4} - .14361 
1 HC 
 
0.967050 0.948525 0.071492 
2 PD-N 0.967050 
 
0.855584 0.170213 
3 PD-MCI 0.948525 0.855584 
 
0.148373 
4 PD-D 0.071492 0.170213 0.148373 
 
 
MD 
Newman-Keuls test; variable FA (raIPL) Approximate Probabilities for Post Hoc Tests Error: 
Between MSE = .00022, df = 135.00 
 
Group {1} - .13657 {2} - .13561 {3} - .13632 {4} - .14361 
1 HC 
 
0.967050 0.948525 0.071492 
2 PD-N 0.967050 
 
0.855584 0.170213 
3 PD-MCI 0.948525 0.855584 
 
0.148373 
4 PD-D 0.071492 0.170213 0.148373 
 
 
Grey Matter  
Newman-Keuls test; variable Grey Matter Voxel (raIPL GM) Approximate Probabilities for 
Post Hoc Tests Error: Between MSE = 1482.4, df = 135.00 
 
Group {1} - 235.03 {2} - 238.25 {3} - 213.29 {4} - 222.67 
1 HC 
 
0.751380 0.081696 0.223390 
2 PD-N 0.751380 
 
0.066657 0.274783 
3 PD-MCI 0.081696 0.066657 
 
0.355659 
4 PD-D 0.223390 0.274783 0.355659 
 
 
 
 
 
